即将招募
Phase 2
药物
clinicaltrials.gov
NCT07511894
海外临床试验导航
胃癌
帮助用户按胃癌、胃食管结合部癌、HER2、CLDN18.2、PD-L1、MSI-H 等方向检索海外公开临床试验。
Synced trials
当前同步到的治疗类试验
以下记录来自公开临床试验数据库，已按招募状态、治疗目的、干预类型和癌症相关性做初步过滤。本站不判断患者是否符合入组条件，请以官方页面、医生和研究团队意见为准。
招募状态和入组条件可能随时变化。请以官方页面、医院和研究机构信息为准，并带给主治医生或肿瘤科医生讨论。
状态
全部
试验阶段
全部
治疗类型
全部
国家/地区
全部
即将招募
Phase 1
生物制剂
clinicaltrials.gov
NCT06134960
NKG2D/CLDN18.21 CAR-T(KD-496) in the Treatment of Advanced NKG2DL+/CLDN18.2+ Solid Tumor
正在招募
Phase 2
药物
clinicaltrials.gov
NCT06846346
Testing Ivonescimab in Combination With Chemotherapy in Advanced or Metastatic Gastric/Gastroesophageal Adenocarcinoma
即将招募
Phase 2
药物
clinicaltrials.gov
NCT06365008
Sintilimab Plus FOLFIRI as Second-line Therapy for Patients With HER2-negative Advanced Gastric Cancer
正在招募
阶段未标明
药物
clinicaltrials.gov
NCT04047953
Paclitaxel (Albumin-bound) Combined With Oxaliplatin and S-1 Conversion Therapy for Gastric Adenocarcinoma
正在招募
Phase 1
药物
clinicaltrials.gov
NCT07066657
A Study of MRG007 (ARR-217) in Patients With Advanced Solid Tumors
正在招募
Phase 2
药物
clinicaltrials.gov
NCT06560528
Disitamab Vedotin Combined With Tislelizumab and Capecitabine in the Perioperative Treatment of Locally Advanced Gastric Cancer With HER2 Overexpression
即将招募
Phase 3
药物
clinicaltrials.gov
NCT05610332
Clinical Efficacy in Neoadjuvant Treatment of Locally Advanced Gastric Cancer With Different Immunotypes
正在招募
阶段未标明
药物手术/操作
clinicaltrials.gov
NCT04595929
Oncological Benefits of Pressured Intraperitoneal Aerosol Chemotherapy (PIPAC) in Patients With T3-4 Gastric Cancer Cyt-
正在招募
Phase 1
药物
clinicaltrials.gov
NCT06253871
A Phase 1/1b Study of IAM1363 in HER2 Cancers
即将招募
Phase 1, Phase 2
药物
clinicaltrials.gov
NCT07364422
To Evaluate the Safety and Tolerability of Study Drug as a Third-line and Beyond Therapy for Recurrent or Metastatic Gastric Cancer
正在招募
Phase 1
生物制剂
clinicaltrials.gov
NCT06910657
IDOV-Immune for Advanced Solid Tumors
即将招募
Phase 2
药物
clinicaltrials.gov
NCT06094868
Clinical Study of Fruquintinib Combined With Sintilimab and XELOX Regimen in the Treatment of Advanced Cancer
正在招募
Phase 3
药物
clinicaltrials.gov
NCT07315750
A Study of Disitamab Vedotin Combined With Trastuzumab and Tislelizumab Versus Chemotherapy Combined With Trastuzumab With or Without Pembrolizumab in HER2-high Expression Advanced Gastric or Gastroesophageal Junction Adenocarcinoma.
即将招募
Phase 2, Phase 3
药物
clinicaltrials.gov
NCT06977061
Efficacy and Safety of Fruquintinib Combined With Sintilimab and Stereotactic Body Radiation Therapy (SBRT) for the Second-line and Higher-line Treatment of Gastric or Gastroesophageal Junction Adenocarcinoma With Oligometastatic Progression
正在招募
Phase 2
药物
clinicaltrials.gov
NCT07263386
A Phase II, Multicenter, Randomized, Controlled Clinical Study Comparing the Efficacy and Safety of Sintilimab Plus SOX Versus SOX Alone as Adjuvant Therapy for PD-L1-Positive, Stage pN3 Gastric Cancer
即将招募
Phase 2
药物
clinicaltrials.gov
NCT06551896
Pemigatinib and Immune Checkpoint Inhibitor Treated FGFR1/2/3 Alteration Advanced Solid Tumor
即将招募
Phase 2
药物
clinicaltrials.gov
NCT06310473
Neoadjuvant Cadonilimab Plus Chemotherapy for Locally Advanced Esophagogastric Junction and Gastric Cancer Trial
即将招募
阶段未标明
手术/操作
clinicaltrials.gov
NCT07237126
Single-port Robotic Radical Gastrectomy for Gastric Cancer
即将招募
Phase 2
药物
clinicaltrials.gov
NCT07515625
Efficacy of Sintilimab Combined With Bevacizumab and XELOX/SOX in Initially Unresectable AFP-positive Gastric/Gastroesophageal Junction Adenocarcinoma
正在招募
Phase 1
药物
clinicaltrials.gov
NCT07227168
A Study of STRO-004 in Adults With Refractory/Recurrent Metastatic Cancer
即将招募
阶段未标明
药物手术/操作
clinicaltrials.gov
NCT06603974
The Efficacy and Safety of Benmelstobart for GC/EGC
正在招募
Phase 1, Phase 2
药物
clinicaltrials.gov
NCT04421820
BOLD-100 in Combination With FOLFOX for the Treatment of Advanced Solid Tumours
正在招募
Phase 2
药物
clinicaltrials.gov
NCT06630130
Perioperative Therapies in Locally Advanced Unresectable Gastric Cancer
即将招募
Phase 2
药物
clinicaltrials.gov
NCT06904300
Ivonescimab (AK112) Plus Paclitaxel as Second-line Therapy in Patients With Advanced G/GEJ Cancer
即将招募
Phase 4
手术/操作
clinicaltrials.gov
NCT07467174
RCT Comparing Reduced-port Robotic and Conventional Laparoscopic Subtotal Gastrectomy
正在招募
Phase 2
药物放疗
clinicaltrials.gov
NCT06555471
A Single-arm, Phase II Exploratory Study of Sintilimab in Combination With Chemoradiotherapy in Elderly Patients With Locally Advanced Gastric Cancer
正在招募
阶段未标明
手术/操作
clinicaltrials.gov
NCT05344339
Billroth-II Modified Versus Roux-en-Y After Distal Gastrectomy for Gastric Cancer
即将招募
阶段未标明
手术/操作
clinicaltrials.gov
NCT06892392
Application of Indocyanine Green Tracer in D2 Lymphadenectomy of Locally Advanced Gastric Cancer
即将招募
Phase 2
药物
clinicaltrials.gov
NCT07233850
A Phase II Clinical Study Evaluating SSGJ-706 in Combination Therapy for Advanced Gastrointestinal Cancers
正在招募
Phase 2
药物手术/操作
clinicaltrials.gov
NCT07655024
TAIC FOLFOX for Locally Advanced G/GEJA
正在招募
Phase 1, Phase 2
药物
clinicaltrials.gov
NCT06239194
Dose Escalation and Dose Expansion Study of MDX2001 in Patients With Advanced Solid Tumors
即将招募
EARLY / Phase 1
药物
clinicaltrials.gov
NCT07394205
Clinical Study of CBG131 CAR-T Cell Injection for the Treatment of CLDN18.2-Positive Advanced Gastric and Pancreatic Cancer
正在招募
阶段未标明
手术/操作
clinicaltrials.gov
NCT05537129
Laparoscopic vs Open Total Gastrectomy for Gastric Cancer
正在招募
Phase 2
药物
clinicaltrials.gov
NCT05715931
Perioperative Chemotherapy Plus Trastuzumab Plus Toripalimab in HER2 Positive Locally Advanced Gastric or Esophagogastric Junction Adenocarcinoma
即将招募
Phase 4
药物
clinicaltrials.gov
NCT07502027
A Clinical Study of Iparomlimab and Tuvonralimab Combined With SOX Following Heterogeneous Radiotherapy as First-line Treatment for Unresectable Locally Advanced or Metastatic HER2-negative Gastric or Gastroesophageal Junction Adenocarcinoma
正在招募
Phase 2
药物
clinicaltrials.gov
NCT05476796
Oxaliplatin ± Nivolumab in Combination With Trifluridine/Tipiracil or 5-fluorouracile in Frail Patients With Advanced, Recurrent or Metastatic Gastric, Oesophageal or Gastroesophageal Junction Cancer
正在招募
Phase 1
诊断检测药物
clinicaltrials.gov
NCT07660055
Study of [177Lu]Lu-DWJ155 and [68Ga]Ga-DWJ155 in Patients With Solid Tumors
即将招募
Phase 2, Phase 3
药物其他
clinicaltrials.gov
NCT07603349
Adaptive Adjuvant Therapy After Neoadjuvant Therapy and Gastrectomy for Gastric or Gastroesophageal Junction Adenocarcinoma
正在招募
Phase 1, Phase 2
联合产品
clinicaltrials.gov
NCT05640609
Capeox Regimen Combined With Sintilimab and Bevacizumab for Gastric Cancer
正在招募
Phase 1, Phase 2
药物
clinicaltrials.gov
NCT06650332
Cadonilimab Combination Regimen as First-line Treatment for HER2-expressing GC/GEJ Patients
正在招募
Phase 3
联合产品
clinicaltrials.gov
NCT05303714
PIPAC in Multimodal Therapy for Patients with Oligometastatic Peritoneal Gastric Cancer
正在招募
Phase 2
药物
clinicaltrials.gov
NCT06023758
Phase 2 Trial of KN026+KN046±XELOX in HER2-positive Locally Advanced GC
即将招募
Phase 2
药物
clinicaltrials.gov
NCT07391826
Megestrol Acetate Oral Suspension for Cachexia in Patients With cStage III Gastric/Gastroesophageal Junction Adenocarcinoma Receiving Neoadjuvant Therapy With Serplulimab Combined With SOX
正在招募
Phase 1, Phase 2
药物
clinicaltrials.gov
NCT07025889
IBI343 Combined With Sintilimab Plus Chemotherapy in Gastric Cancer
正在招募
Phase 1
药物
clinicaltrials.gov
NCT06974110
Study of Orally Administered MOMA-341 in Participants With Advanced or Metastatic Solid Tumors
正在招募
Phase 3
药物
clinicaltrials.gov
NCT06296706
A Clinical Study of Docetaxel for Injection (Albumin-bound) in Patients With Gastric Cancer
正在招募
Phase 1, Phase 2
药物
clinicaltrials.gov
NCT05894824
T-Dxd in Combination With Ramucirumab as HER2 Low Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma
即将招募
Phase 2
药物
clinicaltrials.gov
NCT07621562
Tafolecimab Combined With Sintilimab and SOX in the Treatment of pMMR/MSS Gastric Cancer
正在招募
Phase 3
药物
clinicaltrials.gov
NCT06123494
SHR-A1811 for Subjects With Her2-positive Gastric Cancer and Gastroesophageal Junction Adenocarcinoma After Progression on or After First-line Anti-HER2 Therapy-containing Regimen
即将招募
Phase 2
生物制剂药物
clinicaltrials.gov
NCT06283121
A Clinical Study of BioTTT001 in Combination With SOX and Toripalimab in Patients With Gastric Cancer
正在招募
阶段未标明
手术/操作
clinicaltrials.gov
NCT04843215
A Phase III Study Comparing Total and Partial Omentectomy for Patients With Advanced Gastric Cancer
正在招募
阶段未标明
手术/操作
clinicaltrials.gov
NCT05180864
Omentum Preservation Versus Complete Omentectomy in Gastrectomy for Gastric Cancer
正在招募
Phase 2, Phase 3
药物
clinicaltrials.gov
NCT07221149
A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Nivolumab in Combination With Chemotherapy in Participants With Previously Untreated Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma (ROSETTA Gastric-204)
正在招募
阶段未标明
手术/操作
clinicaltrials.gov
NCT06105515
Laparoscopic and Endoscopic Collaborative Surgery as Rescue-treatment for Advanced Gastric Cancer
正在招募
Phase 2
联合产品
clinicaltrials.gov
NCT06405113
FMT+SOX+Sintilimab As First-line Treatment for Advanced Gastric Cancer
正在招募
Phase 1, Phase 2
生物制剂
clinicaltrials.gov
NCT06006390
CEA Targeting Chimeric Antigen Receptor T Lymphocytes (CAR-T) in the Treatment of CEA Positive Advanced Solid Tumors
即将招募
Phase 2
药物
clinicaltrials.gov
NCT07507526
A Study of Disitamab Vedotin, Tunlametinib, and PD-1 Antibody for Advanced Gastric Cancer
正在招募
Phase 1
联合产品药物其他
clinicaltrials.gov
NCT06789172
A Phase 1, First-in-human Study of OKN4395 and Pembrolizumab in Patients With Solid Tumors
正在招募
Phase 1, Phase 2
生物制剂
clinicaltrials.gov
NCT07341737
SL-28 for Advanced Solid Tumours
正在招募
Phase 2, Phase 3
药物手术/操作
clinicaltrials.gov
NCT06232434
An Open Prospective Randomized Clinical Study of the Effectiveness, Tolerability and Safety of a Single Intraperitoneal Use of the Drug "Prospidelong, Powder for the Preparation of a Gel for Topical Use, 1000 mg in Vials, Package No. 1" in Patients With Disseminated Gastric Cancer, Phase I-II
即将招募
Phase 2
药物其他
clinicaltrials.gov
NCT06942663
Randomized Phase II Trial Evaluating DFS in The Absence of an Adjuvant Component of Perioperative Chemotherapy in Patients With Gastric Cancer
即将招募
Phase 1
药物
clinicaltrials.gov
NCT07358884
First in Human Study of QLS5316 in Solid Tumors
正在招募
Phase 1
药物
clinicaltrials.gov
NCT07298200
Clinical Trial on the Safety, Tolerance and Preliminary Efficacy of XH001 Injection Combined With Neoantigen Vaccine-induced Tumor-specific T-cell Injection in Advanced Gastric Cancer
正在招募
Phase 1, Phase 2
药物
clinicaltrials.gov
NCT04592211
Pembrolizumab, Olaparib, Recurrent/Advanced Gastric and Gastro-esophageal Junction(GEJ) Cancer
正在招募
Phase 1, Phase 2
药物
clinicaltrials.gov
NCT06047379
Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis
正在招募
Phase 2
药物
clinicaltrials.gov
NCT04278222
Anlotinib Plus Toripalimab as First-line Treatment for Advanced Gastric Cancer With ECOG 2 (APICAL-GC)
正在招募
Phase 1, Phase 2
药物
clinicaltrials.gov
NCT03539822
Cabozantinib Plus Durvalumab With or Without Tremelimumab in Patients With Gastroesophageal Cancer and Other Gastrointestinal Malignancies
即将招募
Phase 4
药物
clinicaltrials.gov
NCT05498766
Effect and Safety of Huaier Granule Versus SOX Regimen in Gastric Cancer Patients
正在招募
Phase 1, Phase 2
药物
clinicaltrials.gov
NCT06742411
XELOX Combined With Sintilimab and HBO for Advanced or Metastatic GC/GEJC
正在招募
Phase 2
药物
clinicaltrials.gov
NCT04069273
Novel SEQUEnced Immunotherapy With Anti-angiogenesis and Chemotherapy in Advanced gastroesophageaL Adenocarcinoma
正在招募
Phase 1, Phase 2
药物
clinicaltrials.gov
NCT06776770
A Phase Ib/II Study of Adebrelimab in Combination with Capecitabine and Oxaliplatin in Cancer
正在招募
阶段未标明
手术/操作
clinicaltrials.gov
NCT05494086
Dual-Port Laparoscopic Distal Gastrectomy for Gastric Cancer
正在招募
Phase 3
药物
clinicaltrials.gov
NCT06901531
A Study of Zolbetuximab Together With Pembrolizumab and Chemotherapy in Adults With Gastric Cancer
正在招募
Phase 2
药物
clinicaltrials.gov
NCT07102901
Safety and Efficacy of SHR2554 Combined With Other Antitumor Therapies in Gastric or Gastro-oesophageal Junction Adenocarcinoma
正在招募
Phase 2
药物
clinicaltrials.gov
NCT06008054
A Study of SI-B003, BL-B01D1+SI-B003 and BL-B01D1+PD-1 Monoclonal Antibody in Patients With Locally Advanced or Metastatic Esophageal Cancer, Gastric Cancer, Colorectal Cancer and Other Gastrointestinal Tumors
正在招募
阶段未标明
放疗
clinicaltrials.gov
NCT04368702
CONFIRM: Magnetic Resonance Guided Radiation Therapy
即将招募
Phase 2
药物
clinicaltrials.gov
NCT06447636
Perioperative Surufatinib Plus Sintilimab Combined With Chemotherapy in Gastric/Gastroesophageal Junction Adenocarcinoma
正在招募
Phase 1, Phase 2
药物
clinicaltrials.gov
NCT06395519
A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies
即将招募
阶段未标明
药物手术/操作
clinicaltrials.gov
NCT07452471
Comparison of the Postoperative Analgesic Effects of the Temperature-responsive Gel Mixed With Local Anesthetics Application and Ultrasound-guided Transversus Abdominis Plane Block in Patients Undergoing Laparoscopic Gastrectomy
正在招募
Phase 1, Phase 2
药物
clinicaltrials.gov
NCT06324357
Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Test Whether it Helps People With Different Types of HER2+ Cancer That Has Spread
正在招募
Phase 1
药物
clinicaltrials.gov
NCT06783569
A First-in-Human Escalation and Expansion Study of Patients With Advanced Solid Tumors
正在招募
Phase 1, Phase 2
药物
clinicaltrials.gov
NCT06921837
A First-in-Human Study Using BDC-4182 as a Single Agent in Advanced Gastric and Gastroesophageal Cancer
正在招募
Phase 2
生物制剂药物
clinicaltrials.gov
NCT06196697
AK104 in Combination With AK112 Plus Chemotherapy(SOX/XELOX) as First-line Treatment for Advanced G/GEJ Cancer
正在招募
Phase 1
生物制剂药物
clinicaltrials.gov
NCT05187182
CA-4948 in Combination With FOLFOX/PD-1 Inhibitor +/- Trastuzumab for Untreated Unresectable Gastric and Esophageal Cancer
正在招募
Phase 2
药物
clinicaltrials.gov
NCT07474324
Disitamab Vedotin Combined With SOX Regimen Versus SOX Alone as Adjuvant Therapy for HER2-Moderate/High Expressing Stage Ⅲ Gastric Cancer: A Prospective, Multicenter, Randomized, Phase Ⅱ Clinical Trial
正在招募
Phase 1
药物放疗
clinicaltrials.gov
NCT06673329
Brodalumab in the Treatment of Immune-Related Adverse Events
即将招募
Phase 2
药物
clinicaltrials.gov
NCT07464756
SHR-1701 With or Without Apatinib in Combination With Chemotherapy as Neoadjuvant Therapy for Gastric Cancer
正在招募
Phase 1
药物
clinicaltrials.gov
NCT07021066
Evaluate the Safety, Tolerability, Pharmacokinetics and Efficacy of BL-M05D1 in Subjects With Solid Tumors
正在招募
Phase 1, Phase 2
药物
clinicaltrials.gov
NCT07488676
A Study of ASP546C in Adults With Gastroesophageal Cancer, Pancreatic Cancer or Other Solid Tumors
正在招募
Phase 1, Phase 2
药物
clinicaltrials.gov
NCT07334431
Fruquintinib Combined With Trastuzumab and XELOX as First-line Treatment in Patients With HER2-positive Advanced Gastric Cancer
即将招募
Phase 2
药物
clinicaltrials.gov
NCT06374901
Tislelizumab Combined With Neoadjuvant Chemotherapy Used in the Perioperative Treatment.
即将招募
Phase 2
药物手术/操作
clinicaltrials.gov
NCT07259473
Factors Influencing Immunotherapy Response in dMMR/MSI-H Gastric/Gastroesophageal Junction Adenocarcinoma
即将招募
Phase 2
药物
clinicaltrials.gov
NCT06241469
Efficacy and Safety of Sintilimab Combined With Nab-paclitaxel and Tegio (aTS) as First-line Treatment of Unresectable Locally Advanced, Recurrent or Metastatic Adenocarcinoma of Gastric and Gastroesophageal Junction，a Phase II Clinical Study
即将招募
Phase 3
药物
clinicaltrials.gov
NCT05914610
Envollizumab Combined With Fruquintinib and SOX Versus SOX for Conversion Therapy in Advanced Gastric Cancer
正在招募
Phase 2
生物制剂药物
clinicaltrials.gov
NCT04379596
Ph1b/2 Study of the Safety and Efficacy of T-DXd Combinations in Advanced HER2-expressing Gastric Cancer (DESTINY-Gastric03)
正在招募
Phase 3
药物其他
clinicaltrials.gov
NCT05226169
Efficacy and Safety oF FErric CarboxymalTose in Patients With Advanced Gastric Cancer(EFFECT-AGC)
正在招募
Phase 4
药物
clinicaltrials.gov
NCT07068607
Efficacy Comparison of Vonoprazan Combined With Different Antibiotics in Dual Therapy for Helicobacter Pylori Eradication: A Prospective, Randomized Controlled Clinical Trial
正在招募
Phase 1
生物制剂
clinicaltrials.gov
NCT06242470
A Study of MGC026 in Participants With Advanced Solid Tumors
即将招募
Phase 1
生物制剂药物
clinicaltrials.gov
NCT06748872
EPITOME-1015-I: a Study to Investigate the Safety and Tolerability of MDG1015 in Patients with Epithelial Ovarian Cancer, Gastroesophageal Adenocarcinoma, Round Cell Liposarcoma And/or Synovial Sarcoma
即将招募
Phase 2
药物
clinicaltrials.gov
NCT05318794
Neoadjuvant Systemic and Peritoneal Chemotherapy for Advanced Gastric Cancer
即将招募
Phase 1, Phase 2
药物
clinicaltrials.gov
NCT07453394
QLS5132 Combination Therapy in Advanced Solid Tumors
正在招募
Phase 2
药物
clinicaltrials.gov
NCT07325630
Perioprative Study of IBI363 in Patients With MHC-II-Negative Locally Advanced Gastric Cancer
正在招募
Phase 3
药物
clinicaltrials.gov
NCT06764875
A Phase Ⅲ Study of Rilvegostomig in Combination With Fluoropyrimidine and Trastuzumab Deruxtecan as the First-line Treatment for HER2-positive Gastric Cancer
正在招募
Phase 1
生物制剂
clinicaltrials.gov
NCT06010862
Clinical Study of CEA-targeted CAR-T Therapy for CEA-positive Advanced/Metastatic Malignant Solid Tumors
即将招募
Phase 2
药物
clinicaltrials.gov
NCT07610629
Retlirafusp Alfa Combined With Apatinib and Nab-Paclitaxel as Second-line Treatment for Gastric or Gastroesophageal Junction Cancer
即将招募
Phase 2
药物
clinicaltrials.gov
NCT07581405
GI-05: The Impact of Olanzapine Among Patients Receiving Neoadjuvant Chemotherapy for Gastric Cancer
正在招募
Phase 2
药物
clinicaltrials.gov
NCT07223424
Patient Preference for Subcutaneous vs. Intravenous Immune Therapy
正在招募
Phase 1
药物
clinicaltrials.gov
NCT06293898
Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors
正在招募
Phase 2
药物
clinicaltrials.gov
NCT07069712
A Study of Novel Agents or Combinations as Perioperative Treatment in Participants With Locally Advanced Resectable Gastroesophageal Adenocarcinoma
正在招募
Phase 3
药物
clinicaltrials.gov
NCT06949033
Neoadjuvant Cadonilimab Combined With Perioperative Oxaliplatin Plus S1 for Diffuse or Mixed Type of Locally Advanced Gastric/Gastroesophageal Junction Adenocarcinoma
正在招募
Phase 2, Phase 3
生物制剂药物
clinicaltrials.gov
NCT07392892
Symbiotic-GI-16: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Gastroesophageal Cancer
即将招募
阶段未标明
手术/操作
clinicaltrials.gov
NCT06511609
The Anti-reflux Effect of Double-flap Technique in Laparoscopic Proximal Gastrectomy.
正在招募
阶段未标明
放疗
clinicaltrials.gov
NCT04221893
Radiation Therapy for the Treatment of Metastatic Gastrointestinal Cancers
即将招募
Phase 2
器械药物
clinicaltrials.gov
NCT07304258
A Prospective, Phase II Clinical Study of HIPEC Combined With NIPS and Tislelizumab Conversion Therapy for Gastric Cancer With Peritoneal Metastasis With Positive Cytology Alone or PCI Score ≤10
正在招募
Phase 1, Phase 2
联合产品药物
clinicaltrials.gov
NCT03526835
A Study of Bispecific Antibody MCLA-158 in Patients With Advanced Solid Tumors
正在招募
Phase 1
生物制剂
clinicaltrials.gov
NCT07593820
A Phase I Interventional Open-label, Non-randomized Dose-escalation Trial to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, Immunogenicity, and Preliminary Anti-tumor Activity of Autologous p95HER2.CAR-TECH2Me T Cells in Patients With Selected Advanced Cancers.
正在招募
Phase 2
药物
clinicaltrials.gov
NCT06253650
Adjuvant TRastuzumab Deruxtecan for HER2-positive Gastroesophageal Cancer With Persistence of miNImal Residual Disease
即将招募
Phase 2
药物
clinicaltrials.gov
NCT06339216
A Clinical Study of Adebrelimab Combined With Apatinib and Paclitaxel in Patients With Advanced Gastric Cancer.
正在招募
Phase 2
药物
clinicaltrials.gov
NCT07176312
Zanidatamab in Combination With Pembrolizumab and Chemotherapy in HER2 and PD-L1 Positive Metastatic Gastroesophageal Adenocarcinoma (GEA) Patients
即将招募
EARLY / Phase 1
生物制剂
clinicaltrials.gov
NCT05447234
TCRx_T Cells for Advanced or Recurrent Gastric/Gastroesophageal Junction Cancer After Failure of First Chemotherapy
即将招募
Phase 2
药物
clinicaltrials.gov
NCT06881017
Establishment of Precision Targeted Therapy Strategies for Advanced Gastric Cancer Based on Novel Molecular Subtyping
即将招募
Phase 1
药物
clinicaltrials.gov
NCT07036185
A Clinical Trail of KJ015 in Patients With HER2-Expressing Solid Tumors
正在招募
Phase 1, Phase 2
药物
clinicaltrials.gov
NCT07151040
Phase 1/2 Study to Evaluate TH9619 in the Treatment of Advanced Solid Tumors
正在招募
Phase 3
药物
clinicaltrials.gov
NCT07023315
A Phase III Clinical Study of Cadonilimab Plus SOX as Perioperative Treatment for Patients With Resectable G/GEJ Adenocarcinoma
即将招募
Phase 1
生物制剂药物手术/操作
clinicaltrials.gov
NCT07594548
Futibatinib With Paclitaxel and Ramucirumab for the Treatment of Locally Advanced or Unresectable Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma
正在招募
Phase 2
药物
clinicaltrials.gov
NCT06383559
Safety and Efficacy of XELOX Combined With Sintilimab and Lenvatinib in Advanced AFP-positive Gastric Cancer Patients
即将招募
Phase 2
药物手术/操作
clinicaltrials.gov
NCT07257380
Feasibility of Circulating Tumor DNA Based Minimal Residual Disease-Guided Adjuvant Therapy in Locally Advanced Gastric Cancer With Neoadjuvant Treatment: An Adaptive Trial (MRD-ATLAS)
正在招募
Phase 1, Phase 2
生物制剂药物
clinicaltrials.gov
NCT07551362
Dual-target CLDN18.2/HER2 CAR-NK Cells for Advanced Gastric/GEJ Cancer
正在招募
Phase 1
药物
clinicaltrials.gov
NCT05581004
A Study to Evaluate the Safety, Pharmacokinetics, and Activity of Enzelkitug as a Single Agent and in Combination With Checkpoint Inhibitor in Participants With Locally Advanced or Metastatic Solid Tumors
正在招募
Phase 2
药物
clinicaltrials.gov
NCT06947291
Safety and Efficacy of Glumetinib Combined With Docetaxel for Injection (Albumin-bound) in Patients With Advanced Gastric Cancer/Gastroesophageal Junction Adenocarcinoma and Other Solid Tumors
正在招募
Phase 2
药物
clinicaltrials.gov
NCT05489211
Study of Dato-DXd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03)
正在招募
Phase 2
药物
clinicaltrials.gov
NCT05033392
PD-1 Blockade With JS001 Plus Neoadjuvant Chemotherapy for Gastric/Gastroesophageal Junction Cancer
正在招募
Phase 1
药物
clinicaltrials.gov
NCT05365581
A Study of ASP2138 Given by Itself or Given With Other Cancer Treatments in Adults With Stomach Cancer, Gastroesophageal Junction Cancer, or Pancreatic Cancer
正在招募
阶段未标明
手术/操作
clinicaltrials.gov
NCT05514769
Proximal Gastrectomy Anterior Anastomosis With Pyloroplasty Versus Esophagogastric Anastomosis for Gastric Cancer
正在招募
阶段未标明
手术/操作
clinicaltrials.gov
NCT07482566
Proximal Versus Total Gastrectomy for Locally Advanced Siewert Type II-III Gastroesophageal Junction Cancer
正在招募
阶段未标明
放疗
clinicaltrials.gov
NCT04498767
Stereotactic Body Radiotherapy in Patients With Rare Oligometastatic Cancers (OligoRARE)
正在招募
Phase 2
药物放疗
clinicaltrials.gov
NCT06791148
Low-dose Radiotherapy Combined With Chemotherapy and AK112 as Second-line Treatment in Patients With Advanced G/GEJ Cancer
即将招募
Phase 2
药物
clinicaltrials.gov
NCT06238167
Tislelizumab Plus Chemotherapy as Postoperative Adjuvant Therapy in Elderly Patients With LA GC/GEJC
即将招募
Phase 1, Phase 2
药物
clinicaltrials.gov
NCT06426654
Sintilimab Combined With LDRT for Neoadjuvant Treatment of Locally Advanced dMMR/MSI-H Gastric Cancer
正在招募
阶段未标明
手术/操作
clinicaltrials.gov
NCT06768463
Cytoreductive Gastrectomy After Systemic Therapy Versus Systemic Therapy Alone For Limited Metastasis Gastric Cancer
即将招募
阶段未标明
手术/操作
clinicaltrials.gov
NCT07401303
Full-time RDI for ESD: Impact on Major Adverse Events and Procedure Time
即将招募
Phase 2
药物
clinicaltrials.gov
NCT06697366
Liposomal Irinotecan Combined with Sintilimab for Second-line Treatment of Progressive Gastric Cancer
即将招募
Phase 2
联合产品
clinicaltrials.gov
NCT06980389
Node-Sparing Short-Course Radiotherapy Plus First-Line Therapy and PD-1 Inhibitor in Unresectable/Metastastic pMMR/MSS Gastric Cancer (MODIFI-GC)
即将招募
Phase 2
药物
clinicaltrials.gov
NCT06349967
Nab-paclitaxel Combined With Cadonilimab (AK104) for the Second-line Treatment of Advanced Gastric Cancer
即将招募
Phase 2
药物
clinicaltrials.gov
NCT06998771
JSKN003 Combined Treatment of HER2-positive Gastric Cancer
即将招募
Phase 3
药物
clinicaltrials.gov
NCT04384601
Dragon III-Phase 3: Neoadjuvant Chemotherapy (FLOT Versus SOX) for Gastric Cancer
正在招募
Phase 1, Phase 2
药物
clinicaltrials.gov
NCT05640830
Trastuzumab, Bevacizumab with Paclitaxel for HER2-positive Gastric Cancer in a Second-line Therapy
即将招募
Phase 1
药物放疗
clinicaltrials.gov
NCT07453875
LDRT Sequential NIPS Immunochemotherapy for Peritoneal Metastasis of Gastric and Colorectal Cancer
正在招募
Phase 3
药物
clinicaltrials.gov
NCT04787354
Optimal Duration of Oxaliplatin in Adjuvant XELOX for Gastric Cancer Patients (EXODOX)
即将招募
Phase 2, Phase 3
联合产品
clinicaltrials.gov
NCT05300945
HIPEC Combined Gastrectomy in Patients With Advanced Gastric Cancer Received Neoadjuvant Chemotherapy
即将招募
Phase 2
药物
clinicaltrials.gov
NCT06914687
Efficacy of Tirellizumab Combined With Oral, Intravenous and Abdominal Chemotherapy in Peritoneal Metastatic Gastric/Gastroesophageal Junction Adenocarcinoma
正在招募
Phase 1
联合产品药物
clinicaltrials.gov
NCT07358806
Study to Assess the Effect of OCT-598 in Patients With Advanced Solid Tumors
正在招募
Phase 2
药物
clinicaltrials.gov
NCT06333314
Dostarlimab for Locally Advanced or Metastatic Cancer (Non-colorectal/Non-endometrial) With Tumor dMMR/MSI
即将招募
Phase 1, Phase 2
药物
clinicaltrials.gov
NCT06592287
The Combination of Adebrelimab, Apatinib, and Lrinotecan Liposome for Second-line Treatment of Advanced Gastric Cancer
正在招募
EARLY / Phase 1
药物
clinicaltrials.gov
NCT07595237
A IIT Study of 177Lu-DOTA-SNA040
正在招募
Phase 3
药物放疗
clinicaltrials.gov
NCT04997837
Study of Adjuvant Chemotherapy With or Without PD-1 Inhibitors and Chemoradiotherapy in Resected pN3 Gastric (G) or GEJ Adenocarcinoma
即将招募
Phase 3
生物制剂
clinicaltrials.gov
NCT06944496
A Study of Disitamab Vedotin Combined With Tislelizumab and Chemotherapy Versus Tislelizumab Combined With Chemotherapy in HER2-Low Advanced Gastric or Gastroesophageal Junction Adenocarcinoma
正在招募
Phase 2
药物
clinicaltrials.gov
NCT06632262
A Phase 2 Clinical Study of ABSK061 and ABSK043
正在招募
Phase 2
药物其他
clinicaltrials.gov
NCT06962137
Phase II RAINSPOT: Zolbetuximab-Paclitaxel-Ramucirumab for CLDN18.2 Positive Gastro-esophageal Cancer
正在招募
阶段未标明
放疗
clinicaltrials.gov
NCT07607119
PULSAR Combined With Immunotherapy for Unresectable Locally Advanced Gastric Cancer
正在招募
Phase 1, Phase 2
联合产品药物
clinicaltrials.gov
NCT07371663
An Phase Ib/II Clinical Trial of TCC1727 Combination Therapy in Advanced Solid Tumors
正在招募
Phase 2, Phase 3
药物
clinicaltrials.gov
NCT06221748
DV Combined With Cadonilimab in Subjects With HER2-expressing Gastric Cancer and Gastroesophageal Junction Adenocarcinoma After Progression on First-line Therapy
正在招募
Phase 2
药物
clinicaltrials.gov
NCT06172478
A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
正在招募
Phase 2
药物
clinicaltrials.gov
NCT06054906
Neoadjuvant of Sintilimab Combined Weekly Metronomic Chemotherapy (PLOF) for Resectable Locally Advanced Gastric Cancer
正在招募
阶段未标明
手术/操作
clinicaltrials.gov
NCT04710758
Multicenter Study on Laparoscopic Total Gastrectomy for Advanced Gastric Cancer
正在招募
Phase 3
药物
clinicaltrials.gov
NCT07518147
A Study Comparing BL-M05D1 With the Investigator's Choice of Treatment Regimen in Patients With Claudin (CLDN)18.2-Positive Advanced Gastric Cancer or Gastroesophageal Junction Adenocarcinoma (GC/GEJC) Who Have Received Prior First-Line Treatment
正在招募
Phase 2
药物
clinicaltrials.gov
NCT07289997
Iparomlimab and Tuvonralimab Combined With Apatinib and Irinotecan Hydrochloride for the Treatment of Advanced Alpha-fetoprotein-producing Gastric Cancer (AFPGC)
即将招募
Phase 2
药物手术/操作
clinicaltrials.gov
NCT07621484
HIPEC Priming Followed by Serplulimab Plus SOX/XELOX in Locally Advanced Gastric Cancer
正在招募
阶段未标明
手术/操作
clinicaltrials.gov
NCT06926374
Prospective Evaluation of Cornerstone Robotics Sentire Surgical System in Major Gastrointestinal and Urologic Surgery
正在招募
阶段未标明
手术/操作
clinicaltrials.gov
NCT03385018
Trial for Application of Laparoscopic Total Gastrectomy With Lymph Node Dissection for Gastric Cancer (KLASS-06)
正在招募
Phase 2, Phase 3
药物
clinicaltrials.gov
NCT06988475
DETERMINE Trial Treatment Arm 06: Capmatinib in Adult Patients With Cancers Harbouring MET Dysregulations
正在招募
Phase 1
药物
clinicaltrials.gov
NCT06427941
A Phase 1 Study of BGB-B2033, Alone or in Combination With Tislelizumab With or Without Bevacizumab, in Participants With Advanced or Metastatic Solid Tumors
正在招募
Phase 3
药物
clinicaltrials.gov
NCT01917552
Adjuvant Capecitabine Versus Observation Alone in Curatively Resected Stage IB Gastric Cancer((KCSG ST14-05): CATALYSIS
正在招募
Phase 1, Phase 2
药物
clinicaltrials.gov
NCT07529808
Phase 1/2 Study of BHB810 in Advanced Gastric and GEJ Adenocarcinoma
正在招募
Phase 1, Phase 2
药物
clinicaltrials.gov
NCT07149090
Lenvatinib in Combination With Nivolumab Plus Chemotherapy in Metastatic Gastric Cancer Patients With Malignant Ascites
即将招募
阶段未标明
手术/操作
clinicaltrials.gov
NCT07295002
Sentinel Node Resection With or Without LECS After Noncurative ESD for EGC
正在招募
Phase 2
药物手术/操作放疗
clinicaltrials.gov
NCT03161522
Chemotherapy With or Without Radiation or Surgery in Treating Participants With Oligometastatic Esophageal or Gastric Cancer
正在招募
Phase 2
药物
clinicaltrials.gov
NCT05739045
Nivolumab Combined With SOX Used in the Perioperative Treatment
即将招募
Phase 3
药物
clinicaltrials.gov
NCT07677293
Retlirafusp Alfa Injection Plus Chemotherapy Versus Investigator's Choice of Anti-PD-1 Antibody Plus Chemotherapy as First-line Treatment for Advanced Gastric Cancer With Liver Metastases
正在招募
Phase 2
生物制剂药物
clinicaltrials.gov
NCT06038578
A Study of TRK-950 When Used in Combination With Ramucirumab and Paclitaxel in Patients With Gastric Cancer
正在招募
Phase 2
药物
clinicaltrials.gov
NCT06695845
A Phase 2 Study of Zanidatamab in Patients With HER2-expressing Tumors
即将招募
Phase 1
药物
clinicaltrials.gov
NCT06614751
A PARG Inhibitor DAT-2645 Monotherapy in Patients with Advanced/Metastatic Solid Tumors Harboring BRCA1/2 Loss of Function Alterations And/or Other Defects in the DDR Pathway
即将招募
Phase 2
药物手术/操作
clinicaltrials.gov
NCT06957977
A Randomized Controlled Study of Endoscopic Cryoablation Combined With PD-1 Inhibitor for Maintenance Therapy in Advanced Gastric Cancer
正在招募
Phase 1
药物
clinicaltrials.gov
NCT06999187
A Study of DR-0202 in Patients With Locally Advanced or Metastatic, Relapsed or Refractory Carcinomas
即将招募
Phase 1
生物制剂
clinicaltrials.gov
NCT07031011
PD-1-M1-NK Cells in the Treatment of Advanced Gastric or Colorectal Cancer
正在招募
阶段未标明
手术/操作
clinicaltrials.gov
NCT06679244
Application of a New Surgical Technique in Proximal Gastrectomy: a Prospective, Multicenter Randomized Controlled Study
即将招募
EARLY / Phase 1
药物
clinicaltrials.gov
NCT07166263
Safety and Efficacy of NK510 to Treat Gastric Cancer and Colorectal Cancer
正在招募
Phase 2, Phase 3
药物
clinicaltrials.gov
NCT06028737
Total Neoadjuvant FLOT Chemotherapy in Locally Advanced Gastric and Gastroesophageal Junction Cancer
正在招募
Phase 2
药物手术/操作
clinicaltrials.gov
NCT06468280
Synergistic Effects of PD-1 Antibody and Chemotherapy/Targeted Therapy Followed by Surgery-centric Local Treatment in Patients With Limited-metastatic Gastric Cancer
正在招募
阶段未标明
手术/操作
clinicaltrials.gov
NCT06475170
Preliminary Efficacy Analysis of 'λ+α' Double-Tract Reconstruction After Laparoscopic Proximal Gastrectomy
正在招募
Phase 3
手术/操作
clinicaltrials.gov
NCT03961373
Standard Versus Super-extended Lymphadenectomy After Neo-adjuvant Chemotherapy for Gastric Cancer
正在招募
Phase 2
药物
clinicaltrials.gov
NCT06576921
Efficacy and Safety of Serplulimab Combined With Chemotherapy as Neoadjuvant Treatment for Locally Advanced Gastric Cancer or Adenocarcinoma of Esophagogastric Junction
即将招募
Phase 2
Dietary_Supplement药物
clinicaltrials.gov
NCT07050524
Omega-3 Supplementation and Immunotherapy in Gastric Cancer: A Phase II Trial
正在招募
Phase 2
药物
clinicaltrials.gov
NCT05184803
A Phase 2 Study of Neoadjuvant Docetaxel, Oxaliplatin, S-1 in Patients With Unresectable Locally Advanced or Distant Metastasis Limited to Lymph Node Gastric Cancer
正在招募
Phase 2
联合产品药物
clinicaltrials.gov
NCT03259867
Combination of TATE and PD-1 Inhibitor in Liver Cancer
即将招募
Phase 2
药物
clinicaltrials.gov
NCT06564298
A Study on the Combination of Sintilimab, Ramucirumab and Chemotherapy for First-line Treatment of Gastric Cancer With Liver Metastasis
即将招募
Phase 2
药物手术/操作
clinicaltrials.gov
NCT05095467
HIPEC-AS in Patients With Peritoneal Metastasis of the Stomach or Esophagogastric Junction
正在招募
Phase 1
生物制剂
clinicaltrials.gov
NCT06508307
A Phase I Clinical Study of Intratumoral Injection Oncolytic Vaccinia Virus GC001 in Patient With Advanced Solid Tumors
正在招募
Phase 1, Phase 2
生物制剂药物
clinicaltrials.gov
NCT06469944
Substudy 06C: A Study of Investigational Agents With Pembrolizumab (MK-3475) and Chemotherapy in Participants With First-Line Locally Advanced Unresectable/Metastatic Gastroesophageal Adenocarcinoma (MK-3475-06C/KEYMAKER-U06)
正在招募
Phase 1
生物制剂
clinicaltrials.gov
NCT06043466
A Clinical Trial Targeting CEA Chimeric Antigen Receptor T (CAR-T) for CEA Positive Advanced Malignant Solid Tumors
正在招募
Phase 2
药物
clinicaltrials.gov
NCT06199895
Clinical Efficacy and Safety of Paclitaxel Polymeric Micelles for Injection in the Treatment of Patients With Taxans-resistant Pancreatic Adenocarcinoma, Cholangiocarcinoma, Lung Cancer, Gastric Cancer, Esophageal Carcinoma, or Breast Cancer
正在招募
Phase 1
药物
clinicaltrials.gov
NCT05872295
IKS014 in Advanced Solid Tumors That Express HER2
正在招募
Phase 2
药物
clinicaltrials.gov
NCT06487221
Avutometinib and Defactinib in Diffuse Gastric Cancer
即将招募
阶段未标明
药物其他
clinicaltrials.gov
NCT07098949
Acupuncture Combined With Chemotherapy for Gastric Cancer After Surgery
正在招募
Phase 2
药物
clinicaltrials.gov
NCT03175224
APL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid Tumors
即将招募
Phase 2
药物
clinicaltrials.gov
NCT07631884
Exploratory Study on the Efficacy and Safety of Trastuzumab Rezetecan in the Treatment of HER2-Expressiong Advanced Solid Tumor
正在招募
Phase 2
药物
clinicaltrials.gov
NCT07309185
Adebrelimab Combined With Famitinib and Irinotecan in Advanced Gastric Cancer After Failure of First-Line Therapy
正在招募
阶段未标明
手术/操作
clinicaltrials.gov
NCT06748352
Safety and Efficacy of Traction Robot-assisted Endoscopic Submucosal Dissection for Early Gastric Cancer
即将招募
Phase 2
药物
clinicaltrials.gov
NCT07692204
A Dose Optimization/Expansion Study of SAR445877 in Adult Chinese Participants With Advanced Gastric or Gastroesophageal Junction Cancer
正在招募
Phase 2, Phase 3
药物手术/操作
clinicaltrials.gov
NCT07001748
Testing the Addition of Paclitaxel Administered Into the Abdominal Cavity Combined With Chemotherapy for Patients With Gastric Cancer Spread to the Abdominal Cavity
正在招募
Phase 1, Phase 2
药物
clinicaltrials.gov
NCT07115043
A Study to Investigate Safety of AZD6750 in Adult Participants With Select Advanced or Metastatic Solid Tumors
正在招募
阶段未标明
手术/操作
clinicaltrials.gov
NCT06788548
Fluorescence Guided Laparoscopic-Endoscopic Cooperative Sentinel Lymph Node Navigation Surgery Strategy for Early Gastric Cancer（IDEAL Stage 2b）
正在招募
Phase 1, Phase 2
药物
clinicaltrials.gov
NCT05319639
Phase I/II Study of the Combination of Irinotecan and POF (POFI) and Tislelizumab
即将招募
Phase 2
生物制剂药物手术/操作
clinicaltrials.gov
NCT07583810
Non-covalent BTK Inhibitor Nemtabrutinib in Combination With the CD20 Monoclonal Antibody Rituximab for the Treatment of Marginal Zone Lymphoma
正在招募
Phase 1
生物制剂
clinicaltrials.gov
NCT07179692
CEA-Targeted CAR-T Therapy in CEA-Positive Advanced Solid Tumors
即将招募
Phase 2
药物
clinicaltrials.gov
NCT06942767
Combination of QLS31905, QL2107 and Chemotherapy as First-line Therapy in CLDN18.2-positive Unresectable Locally Advanced or Metastatic Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma
即将招募
Phase 2
药物
clinicaltrials.gov
NCT05970627
Perioperative Chemotherapy Plus Toripalimab for Epstein-Barr Virus-associated Locally Advanced Gastric or Esophagogastric Junction Adenocarcinoma
正在招募
Phase 1
药物
clinicaltrials.gov
NCT04999761
AB122 Platform Study
正在招募
Phase 3
药物
clinicaltrials.gov
NCT06731478
Study of TDXd, Chemotherapy, Pembrolizumab, and Trastuzumab in First-Line Metastatic HER2-Positive Gastric or Gastroesophageal Junction Cancer
即将招募
Phase 1, Phase 2
生物制剂药物
clinicaltrials.gov
NCT07361991
IBI363 Plus Bevacizumab With or Without Nab-Paclitaxel for Second-Line Treatment of Advanced Gastric Cancer
正在招募
Phase 2, Phase 3
药物
clinicaltrials.gov
NCT05699655
Tislelizumab Combined With Apatinib and Oxaliplatin Plus S1 Vs Oxaliplatin Plus S1 as Neoadjuvant Therapy for Borrmann IV、Large Borrmann III Type and Bulky N Positive Advanced Gastric Cancer
正在招募
Phase 2
药物
clinicaltrials.gov
NCT06519591
Systemic Application of Cadonilimab, LM-302, and S-1 Combined With Intraperitoneal Infusion of Paclitaxel for the Treatment of Claudin 18.2-positive Gastric Cancer With Peritoneal Metastasis
正在招募
Phase 1
药物
clinicaltrials.gov
NCT07454642
AVA6103 in Subjects With Locally Advanced or Metastatic Selected Solid Tumors
正在招募
阶段未标明
手术/操作
clinicaltrials.gov
NCT06668454
Chemoimmunotherapy Followed by Surgery for Oligometastatic Esophagogastric Cancer: (TORO Protocol)
正在招募
阶段未标明
手术/操作
clinicaltrials.gov
NCT06346093
Fecal Microbiota Transplantation (FMT) in Patients With Advanced Gastric Cancer
正在招募
Phase 2
药物
clinicaltrials.gov
NCT06791083
Clinical Study of Envafolimab Combined With Fruquintinib and Chemotherapy for Neoadjuvant Treatment of Gastric Cancer
正在招募
Phase 2
药物
clinicaltrials.gov
NCT06730373
First-line Treatment With RC48 Plus Sintilimab and S-1 in Advanced Gastric Cancer (RCTS2)
正在招募
Phase 1
药物
clinicaltrials.gov
NCT07481357
A First-In-Human Phase I/IIa Study to Evaluate DA 3501 in Patients With Advanced Gastric or Gastro-esophageal Junction Adenocarcinoma and Pancreatic Ductal Adenocarcinoma
即将招募
Phase 2, Phase 3
药物手术/操作
clinicaltrials.gov
NCT04677673
Neoadjuvant Chemotherapy Plus Surgery Versus Surgery First For Elderly Gastric Cancer Patients
即将招募
阶段未标明
手术/操作
clinicaltrials.gov
NCT06229197
Billroth II With Braun Anastomosis After Radical Distal Gastrectomy for Gastric Cancer
正在招募
EARLY / Phase 1
药物
clinicaltrials.gov
NCT07034742
Exploratory Study on the Application of Molecular Residual Disease (MRD) in Postoperative Treatment of Gastric Cancer
即将招募
阶段未标明
手术/操作
clinicaltrials.gov
NCT07260461
The Efficacy and Safety of Laparoscopic Proximal Gastrectomy With LPG-tbROSF Versus LTG for Localized Proximal Gastric Cancer.
即将招募
Phase 2
药物
clinicaltrials.gov
NCT06385873
RC48 Combined With Adebrelimab, Apatinib and S-1 as Neoadjuvant Therapy in Locally Advanced Gastric Cancer
正在招募
Phase 1
药物
clinicaltrials.gov
NCT06131840
A Study of SGN-CEACAM5C in Adults With Advanced Solid Tumors
正在招募
Phase 1
生物制剂
clinicaltrials.gov
NCT07544589
A Phase 1 Study Evaluating DISP-10 in Participants With Advanced Gastrointestinal Cancers
正在招募
Phase 1, Phase 2
生物制剂
clinicaltrials.gov
NCT05438459
GAIA-102 Intraperitoneal Administration in Patients With Advanced Gastrointestinal Cancer of Microsatellite Stable With Malignant Ascites
正在招募
Phase 3
药物
clinicaltrials.gov
NCT07362186
LM-108 in Combination With Toripalimab Versus Paclitaxel Injection for the Treatment of Subjects With CCR8-Positive Gastric and Gastroesophageal Junction Adenocarcinoma
正在招募
Phase 3
药物手术/操作
clinicaltrials.gov
NCT04483076
Oxaliplatin Combined With S-1(SOX) Neoadjuvant Chemotherapy for Different Cycles in Patients With Gastric Cancer
正在招募
Phase 2
药物
clinicaltrials.gov
NCT07133490
INTERACT Stomach-II
正在招募
Phase 1
生物制剂
clinicaltrials.gov
NCT07001592
Intra-tumoral (IT) Injection of vvDD-hIL2-2-RG-1 for Metastatic Gastrointestinal and Peritoneal Tumors
正在招募
Phase 1
药物
clinicaltrials.gov
NCT05274048
Neratinib and Fam-Trastuzumab Deruxtecan in Advanced Gastro-esophageal Cancer Patients
正在招募
Phase 1
药物
clinicaltrials.gov
NCT07646106
THE-0504 in Patients With Solid Tumors
即将招募
Phase 2
药物
clinicaltrials.gov
NCT07692334
Becotatugvedotin Plus Pucotenlimab in EGFR-Positive Advanced Gastric/GEJ Adenocarcinoma
正在招募
Phase 1
药物
clinicaltrials.gov
NCT05107674
A Study of NX-1607 in Adults With Advanced Malignancies
正在招募
Phase 3
药物
clinicaltrials.gov
NCT05482516
Evaluating Novel Therapies in ctDNA Positive GI Cancers
正在招募
Phase 3
药物
clinicaltrials.gov
NCT06177041
M108 Plus CAPOX Versus Placebo Plus CAPOX as First-line Treatment for Claudin (CLDN) 18.2-Positive, HER2-Negative, PD-L1 CPS<5, Locally Advanced Unresectable or Metastatic Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma.
即将招募
阶段未标明
药物
clinicaltrials.gov
NCT07371871
A Prospective, Single-arm, Exploratory Study of Trifluridine/Tipiracil (TAS-102) Combined With Apatinib as Third-line Therapy for Advanced Gastric Cancer
即将招募
Phase 4
药物
clinicaltrials.gov
NCT06963593
Clinical Study on the Treatment of Anorexia and Cachexia in Advanced Gastric and Esophageal Cancer With Nanosized Megestrol Acetate Combined With Immunochemotherapy
正在招募
Phase 2
生物制剂药物放疗
clinicaltrials.gov
NCT07689851
Chemoradiotherapy and SHR-1701 in Patients With Unresectable Gastric Cancer
正在招募
Phase 3
药物
clinicaltrials.gov
NCT06925243
Neoadjuvant Apatinib Combined With Sintilimab and Perioperative SOX Versus Neoadjuvant Sintilimab Combined With Perioperative SOX for Intestinal Type of Locally Advanced Gastric/Gastroesophageal Junction Adenocarcinoma
即将招募
Phase 2
药物手术/操作
clinicaltrials.gov
NCT07018063
Neoadjuvant Nab-Paclitaxel Plus Oxaliplatin, S-1, and Sintilimab in Early-Onset Resectable Gastric Cancer
正在招募
Phase 2
药物放疗
clinicaltrials.gov
NCT06341595
Concurrent Chemoradiotherapy Combined With Sintilimab as Neoadjuvant Therapy for GC Patients With PALM
正在招募
阶段未标明
手术/操作
clinicaltrials.gov
NCT06627634
Radical Surgery for Advanced Gastric- or GEJ-cancer With Oligometastatic Dissmination to the Liver
即将招募
Phase 2
药物
clinicaltrials.gov
NCT06222944
Anlotinib, TQB2450 (PD-L1 Inhibitor), and Albumin-bound Paclitaxel Regimens in the Treatment of GC/GEJA
正在招募
Phase 1
药物
clinicaltrials.gov
NCT04389632
A Study of Sigvotatug Vedotin in Advanced Solid Tumors
即将招募
Phase 2
药物
clinicaltrials.gov
NCT07689292
Sac-TMT Combined With Fruquintinib as Second-Line Treatment in Patients With Advanced Gastric/Gastroesophageal Junction Adenocarcinoma
即将招募
Phase 2
药物
clinicaltrials.gov
NCT07144657
Prospective Study of Frontline Antibiotics Therapy in the Treatment of Early-stage HP-negative Gastric MALT Lymphoma
正在招募
阶段未标明
手术/操作
clinicaltrials.gov
NCT06690112
Pilot Study for High Output Drainage Removal After Gastrectomy
正在招募
Phase 2
药物
clinicaltrials.gov
NCT06415669
A Study of Paclitaxel Combined With Apatinib and Adebrelimab in Gastric/Gastroesophageal Junction Adenocarcinoma
正在招募
Phase 3
药物
clinicaltrials.gov
NCT07522151
Clinical Study of Adebrelimab Therapy in the Perioperative Treatment of Gastric Cancer or Gastroesophageal Junction Cancer
即将招募
Phase 3
药物
clinicaltrials.gov
NCT07068516
Perioperative Tislelizumab Plus Chemotherapy Versus Chemotherapy Alone in MHC-II-Positive Gastric/GEJ Cancer
正在招募
Phase 1
生物制剂
clinicaltrials.gov
NCT06414733
HER-2 B Cell Peptide Vaccine
正在招募
Phase 1
生物制剂药物手术/操作
clinicaltrials.gov
NCT06364410
Testing the Combination of the Anticancer Drugs Trastuzumab Deruxtecan (DS-8201a) and Azenosertib (ZN-c3) in Patients With Stomach or Other Solid Tumors
正在招募
阶段未标明
药物
clinicaltrials.gov
NCT04688801
Ajuvant Chemotherapy and Immunotherapy in Patients With Esophageal, Esophageal- Gastric Junction Cancer
正在招募
Phase 2
药物
clinicaltrials.gov
NCT05618821
Clinical Outcomes of Indocyanine Green Tracer Using in Laparoscopic Gastrectomy With Lymph Node Dissection for Remnant Gastric Cancer
正在招募
Phase 3
药物
clinicaltrials.gov
NCT05813015
Study of Comparing of With and Without Sequential Therapy of S-1
正在招募
Phase 2
药物
clinicaltrials.gov
NCT06451211
Neoadjuvant Immunotherapy Plus Chemotherapy in Borrmann Type 4 and Large Type 3 Gastric Cancer
正在招募
Phase 1, Phase 2
生物制剂药物手术/操作
clinicaltrials.gov
NCT05269381
Personalized Neoantigen Peptide-Based Vaccine in Combination With Pembrolizumab for Treatment of Advanced Solid Tumors
正在招募
Phase 2
诊断检测药物
clinicaltrials.gov
NCT07517107
Dynamic Circulating Tumor DNA Monitoring to Guide Systemic Therapy in Gastric Cancer
正在招募
Phase 3
药物
clinicaltrials.gov
NCT03941561
S-1 for 9 Months Versus 1 Year for Stage II Gastric Cancer (SMAC）
正在招募
Phase 2
药物
clinicaltrials.gov
NCT07392346
Safety and Efficacy of Fruquintinib Plus Nab-Paclitaxel and Iparomlimab and Tuvonralimab Injection in the Second-Line Treatment for Immunotherapy-experienced Advanced Gastric Cancer
即将招募
Phase 1, Phase 2
药物
clinicaltrials.gov
NCT07509008
Phase 1/2 Window Of Opportunity Study Of TROP2 CAR/IL-15 TGFBR2 KO NK Cells Delivered Intraperitoneally For The Management Of Gastric Cancer Metastatic To The Peritoneum
正在招募
Phase 1
生物制剂
clinicaltrials.gov
NCT06773312
BC001 in Combination with Sintilimab and XELOX in the Treatment of HER-2 Negative Advanced or Metastatic Gastric Cancer or Gastroesophageal Junction Adenocarcinoma.
正在招募
Phase 1, Phase 2
生物制剂
clinicaltrials.gov
NCT03093688
Clinical Safty and Efficacy Study of Infusion of iNKT Cells and CD8+T Cells in Patients With Advanced Solid Tumor
正在招募
Phase 2
药物手术/操作
clinicaltrials.gov
NCT04550494
Measuring the Effects of Talazoparib in Patients With Advanced Cancer and DNA Repair Variations
正在招募
Phase 2
药物
clinicaltrials.gov
NCT05977998
A Phase II Study of Perioperative Paclitaxel in Patients With Gastric Adenocarcinoma and Carcinomatosis or Positive Cytology
即将招募
Phase 2
药物
clinicaltrials.gov
NCT06213519
HIPEC Combined With SOX and Sintilimab in the Treatment of Advanced Gastric Cancer With Peritoneal Metastasis
正在招募
Phase 2, Phase 3
药物手术/操作放疗
clinicaltrials.gov
NCT07000253
Timing of Minimally Invasive Local Treatment After First-Line Systemic Therapy in Oligometastatic Esophageal or Gastric Adenocarcinoma
正在招募
阶段未标明
手术/操作
clinicaltrials.gov
NCT07561073
Comparison of Partial Stomach-Partitioning and Conventional Gastrojejunostomy for the Treatment of Gastric Outlet Obstruction in Advanced Gastric Cancer
正在招募
Phase 2, Phase 3
药物
clinicaltrials.gov
NCT05427383
KN026 in Combination With Chemotherapy in HER2 Positive Gastric Cancer Subjects Who Have Failed First-line Therapy
正在招募
阶段未标明
手术/操作
clinicaltrials.gov
NCT06202105
Comparison of Laparoscopic and Open Total Gastrectomy for Locally Advanced Gastric Cancer
即将招募
Phase 2
药物
clinicaltrials.gov
NCT07126561
Trastuzumab Deruxtecan to Treat HER2 + Newly Diagnosed Metastatic GI Cancers
正在招募
阶段未标明
手术/操作
clinicaltrials.gov
NCT07056010
Efficacy and Safety of Minimally Invasive D2+PAND Gastrectomy for Gastric Cancer With PAN Metastasis After Conversion Immunochemotherapy
即将招募
Phase 3
手术/操作
clinicaltrials.gov
NCT07331454
Robotic vs Laparoscopic Gastrectomy for cT4a Gastric Cancer
正在招募
阶段未标明
手术/操作
clinicaltrials.gov
NCT04295473
Reduced Port Laparoscopic Gastrectomy for Gastric Cancer
即将招募
Phase 4
药物
clinicaltrials.gov
NCT07149181
Comparing the Efficacy and Safety of Chemotherapy Combined With or Without Immunotherapy as Postoperative Adjuvant Regimens in Patients With Resectable Gastric Cancer/Adenocarcinoma of the Esophagogastric Junction After Radical Surgery
正在招募
Phase 1
生物制剂联合产品
clinicaltrials.gov
NCT04282044
Study of CRX100 as Monotherapy and in Combination With Pembrolizumab in Patients With Advanced Solid Malignancies
即将招募
Phase 2
药物
clinicaltrials.gov
NCT04973475
Indocyanine Green Tracer Using in Laparoscopic Distal Gastrectomy for Early Gastric Cancer
正在招募
Phase 2
药物
clinicaltrials.gov
NCT07072728
Psilocybin-Assisted Psychotherapy in Cancer Patients With Adjustment Disorder
正在招募
Phase 1
药物
clinicaltrials.gov
NCT05005403
Study to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma and Other Solid Tumors, Receiving Intravenous Infusion of Azirkitug Alone or in Combination(s) With Budigalimab, Bevacizumab, or Telisotuzumab Adizutecan
正在招募
Phase 2
药物
clinicaltrials.gov
NCT07315854
Iparomlimab and Tuvonralimab (QL1706) Combined With Chemotherapy for Previously Untreated Advanced or Metastatic Gastric or Gastroesophageal Junction Cancer
正在招募
Phase 1
药物
clinicaltrials.gov
NCT04900818
Study of TJ033721 (Givastomig) in Subjects With Advanced or Metastatic Solid Tumors
正在招募
Phase 2
药物
clinicaltrials.gov
NCT06580002
Repurposing Riluzole for Cancer-Related Cognitive Impairment: A Pilot Trial
正在招募
阶段未标明
药物
clinicaltrials.gov
NCT06277024
A Study on the Safety and Efficacy of the Combination of Candenizumab, Lenvatinib, and SOX Regimen in the Treatment of HER2 Negative Advanced Gastric or Gastroesophageal Junction Adenocarcinoma Patients
即将招募
Phase 2
药物
clinicaltrials.gov
NCT07045805
Phase II Study of QL1706 Combined With Paclitaxel and Bevacizumab for Second-Line Immune Rechallenge in Gastric Cancer
正在招募
Phase 3
手术/操作
clinicaltrials.gov
NCT07029269
Feasibility of Enhanced Recovery After Surgery Without Prophylactic Abdominal Drainage Tubes After Laparoscopic Distal Gastrectomy For Gastric Cancer
正在招募
Phase 2
诊断检测手术/操作
clinicaltrials.gov
NCT07282912
Trial Comparing Standard of Care Therapy With and Without Sequential Cytoreductive Intervention for Patients With Metastatic Foregut Adenocarcinoma and Undetectable Circulating Tumor-Deoxyribose Nucleic Acid (ctDNA) Levels
即将招募
Phase 3
联合产品药物
clinicaltrials.gov
NCT05230771
Clinical Outcome of Palliative Surgery After Translational Therapy for Metastatic Gastric Cancer Versus Maintenance Chemotherapy for Metastatic Gastric Cancer
正在招募
Phase 2
药物
clinicaltrials.gov
NCT06685887
A Clinical Study Evaluating the Efficacy of Systemic Chemotherapy and Immune Checkpoint Inhibitors Combined With Hyperthermic Intraperitoneal Chemotherapy in the Treatment of Gastric Cancer Patients With Peritoneal Metastasis
即将招募
Phase 2, Phase 3
药物
clinicaltrials.gov
NCT07332533
A Study of KN026-based Combination Therapy in HER2-positive Gastric Cancer
正在招募
Phase 1
生物制剂药物
clinicaltrials.gov
NCT05483491
KK-LC-1 TCR-T Cell Therapy for Gastric, Breast, Cervical, and Lung Cancer
正在招募
Phase 1, Phase 2
药物
clinicaltrials.gov
NCT04895709
A Study of BMS-986340 as Monotherapy and as Combination Therapy in Participants With Advanced Solid Tumors
即将招募
Phase 2
手术/操作
clinicaltrials.gov
NCT06759233
Endoscopic Cryoablation Combined With PD-1 in Advanced Gastric Cancer
正在招募
Phase 2
药物
clinicaltrials.gov
NCT04107077
Phase II Study of the Effects of Laparoscopic Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Patients With Advanced Gastric Cancer
正在招募
Phase 3
药物
clinicaltrials.gov
NCT06346197
Combination of Immune Checkpoint in Locally Advanced or Metastatic MSI/dMMR Esogastric Adenocarcinomas
正在招募
Phase 1
药物
clinicaltrials.gov
NCT06873659
SON-DP in Participants With Relapsed/Refractory Intolerant to Standard of Care Therapies for Advanced/Metastatic Solid Tumors
正在招募
Phase 1, Phase 2
药物
clinicaltrials.gov
NCT06792435
XNW27011 Study of Advanced Solid Tumor Subjects Who Failed Standard Therapies.
正在招募
Phase 2
药物放疗
clinicaltrials.gov
NCT07007182
Conversion Therapy Plus Surgery and Radiotherapy for Retroperitoneal Nodal Metastases in Gastric Cancer
正在招募
Phase 1
药物
clinicaltrials.gov
NCT07277413
A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors
正在招募
Phase 2
药物
clinicaltrials.gov
NCT06091423
XELOX Combined With Fruquintinib and Sintilimab Regimen Conversion Therapy for Gastric Cancer/Gastroesophageal Junction Adenocarcinoma Only With Liver and/or Retroperitoneal Lymph Node Metastasis, a Prospective Single-arm, Multicenter Study
正在招募
Phase 1, Phase 2
药物
clinicaltrials.gov
NCT06085755
Trastuzumab Deruxtecan(T-DXd) and Afatinib Combination in HER2-low Advanced Gastric Cancer
即将招募
Phase 2
药物
clinicaltrials.gov
NCT06454435
Conversion Therapy of Sintilimab in Combination With Fruquintinib and Chemotherapy Versus Sintilimab and Chemotherpay in Stage IV Gastric Cancer
正在招募
阶段未标明
手术/操作
clinicaltrials.gov
NCT05892289
Feasibility and Safety of Robotic Assisted Proximal Gastrectomy With Double-flap Technique for Proximal Early Gastric Cancer
即将招募
Phase 2
药物其他
clinicaltrials.gov
NCT07602140
TACE Combined With Thermal Ablation and ADC, PD-1, and Chemotherapy as First-line Treatment for HER2-highly-expressing Gastric Cancer With Liver Metastases: A Multicenter, Single-arm Prospective Clinical Study.
即将招募
Phase 2
药物
clinicaltrials.gov
NCT06531291
Surufatinib Combined With Serplulimab and Standard Chemotherapy as First-line Treatment in Advanced Solid Tumors With Neuroendocrine Differentiation
正在招募
Phase 2
药物
clinicaltrials.gov
NCT05494060
XELOX Combined With Anlotinib and Penpulimab vs XELOX as Adjuvant Therapy in ctDNA Positive Gastric and Esophagogastric Junction Adenocarcinoma
正在招募
Phase 2
药物
clinicaltrials.gov
NCT07119463
Effect of Goal-Oriented Albumin Infusion on Postoperative Complication Management in Gastric Cancer Surgery
正在招募
Phase 2
药物
clinicaltrials.gov
NCT04891016
Toripalimab Plus FLOT in Locally Advanced Gastric Cancer
即将招募
阶段未标明
药物
clinicaltrials.gov
NCT07092449
Pucotenlimab Combined With Chemotherapy as Perioperative Treatment for Locally Advanced Gastroesophageal Junction Carcinoma
即将招募
Phase 2
药物手术/操作
clinicaltrials.gov
NCT07266025
Adebrelimab Combined With Induction Chemotherapy or SHR-8068 for Mismatch Repair-Deficient/Microsatellite Instability-High (dMMR/MSI-H) Locally Advanced Gastric/Gastroesophageal Junction Adenocarcinoma：A Randomized, Non-comparative Phase 2 Study
正在招募
Phase 1, Phase 2
药物
clinicaltrials.gov
NCT06759064
Intraperitoneal Immune Checkpoint Inhibitors and Zoledronic Acids for Gastric Cancer Malignant Ascites
即将招募
Phase 2
药物
clinicaltrials.gov
NCT07658872
Perioperative Fruquintinib Combined With Sintilimab and SOX for Locally Advanced Gastric or GEJ Adenocarcinoma
正在招募
Phase 2
药物
clinicaltrials.gov
NCT04840264
Docetaxel, Oxaliplatin and 5-FU for Gastric Cancer With Inoperable Malignant Bowel Obstruction
即将招募
阶段未标明
药物
clinicaltrials.gov
NCT07139587
The Efficacy and Safety of Iparomlimab/Tuvonralimab (Anti PD-1/CTLA-4) Combined With Albumin-bound Paclitaxel in Second-line Treatment of Patients With Advanced Gastric/Gastroesophageal Junction Adenocarcinoma
正在招募
Phase 1
生物制剂
clinicaltrials.gov
NCT05427487
Study of Intratumoral IVX037 in Patients With Advanced or Metastatic Solid Tumours
正在招募
Phase 2
药物
clinicaltrials.gov
NCT05177133
Anti-PD-1 and CapOx for the First-line Treatment of dMMR Esophagogastric Cancer (AuspiCiOus)
正在招募
Phase 2
药物
clinicaltrials.gov
NCT06422403
A Value-Driven Study on Reducing Immune Checkpoint Inhibitor Dosing Frequency in Advanced Cancers
正在招募
Phase 3
药物
clinicaltrials.gov
NCT07304271
Intraperitoneal Paclitaxel and Systemic Therapy Versus Systemic Therapy Alone in Gastric Cancer Patients With Peritoneal Metastasis
正在招募
阶段未标明
药物
clinicaltrials.gov
NCT06158919
A Study of PD-1 Inhibitors Combined With Fruquintinib and Chemotherapy in First-line Treatment of HER2-negative Advanced G/GEJ Cancer
即将招募
Phase 3
药物
clinicaltrials.gov
NCT06870565
Comparative Study of Adjuvant Therapy for Postoperative Cervical Gastric-type Adenocarcinoma
即将招募
Phase 2
药物
clinicaltrials.gov
NCT07638631
Ipilimumab (N01) Plus Sintilimab and Modified XELOX as Conversion Therapy in Unresectable Locally Advanced Gastric Cancer
正在招募
Phase 2
药物
clinicaltrials.gov
NCT05332002
sFOLFOXIRI in Advanced Gastroesophageal Cancer, (SAGE)
即将招募
阶段未标明
手术/操作
clinicaltrials.gov
NCT05890339
Laparoscopic Proximal Gastrectomy With Double-flap Technique Versus Laparoscopic Total Gastrectomy With Roux-en-Y Reconstruction for Proximal Early Gastric Cancer
正在招募
Phase 2
联合产品药物手术/操作
clinicaltrials.gov
NCT06580574
Immune Checkpoint Inhibitors for Organ Preservation in Non-metastatic dMMR/MSI-H Gastric or Colon Cancers
即将招募
阶段未标明
手术/操作
clinicaltrials.gov
NCT05978882
Feasibility Study of Sentinel Navigation Surgery in Early Gastric Cancer Using Fluorescence (SENORITA4)
即将招募
Phase 4
药物
clinicaltrials.gov
NCT06499610
Clinical Study of Irinotecan Liposome Combination Therapy for Advanced Gastric Cancer
正在招募
Phase 1
生物制剂
clinicaltrials.gov
NCT03740256
Binary Oncolytic Adenovirus in Combination With HER2-Specific Autologous CAR VST, Advanced HER2 Positive Solid Tumors
即将招募
阶段未标明
手术/操作
clinicaltrials.gov
NCT05235932
the Clinical Efficacy of Robotic and Laparoscopic Radical Total Gastrectomy in Locally Advanced Middle and Upper Gastric Cancer
正在招募
EARLY / Phase 1
生物制剂
clinicaltrials.gov
NCT06937567
CDH17 CAR-T Therapy in Advanced Malignant Solid Tumors
即将招募
阶段未标明
手术/操作
clinicaltrials.gov
NCT06934824
Clinical Study of Double-Endoscopic Combined With Minimally Invasive Treatment for Early Gastric Cancer at Clinical Stage T1b
正在招募
Phase 1, Phase 2
生物制剂药物
clinicaltrials.gov
NCT03190941
Administering Peripheral Blood Lymphocytes Transduced With a Murine T-Cell Receptor Recognizing the G12V Variant of Mutated RAS in HLA-A*11:01 Patients
即将招募
Phase 2
药物
clinicaltrials.gov
NCT06374888
Nilatinib Maleate Tablets Combined With Capecitabine in the Treatment of HER2-positive Advanced Esophageal/Esophagogastric Junction/Gastric Adenocarcinoma With Brain Metastases
正在招募
Phase 2
药物
clinicaltrials.gov
NCT03825861
Neoadjuvant FOLFIRINOX in the Treatment of Locally Advanced Gastric Cancer
即将招募
Phase 2
药物
clinicaltrials.gov
NCT07033143
Evaluation of the Efficacy and Safety of Adebrelimab Combined With SOX as Adjuvant Therapy for IIIB and IIIC Gastric Cancer
正在招募
阶段未标明
手术/操作
clinicaltrials.gov
NCT05986890
Roux-en-Y Gastric Bypass Versus Loop Gastrojejunostomy for Malignant Gastric Outlet Obstruction
正在招募
阶段未标明
手术/操作
clinicaltrials.gov
NCT06841484
Comparison of Full Robotic Instrumentation and Assistant-Controlled Laparoscopic Instrumentation in Robotic Distal Gastrectomy
正在招募
Phase 1, Phase 2
药物
clinicaltrials.gov
NCT06943521
A Study of MT-4561 in Patients With Various Advanced Solid Tumors
正在招募
Phase 1, Phase 2
药物
clinicaltrials.gov
NCT05482893
Spevatamig (PT886) as Monotherapy or in Combination With Chemo and/or ICI, for the Treatment of Patients With Advanced Gastric, Gastroesophageal Junction, Pancreatic Ductal or Biliary Tract Carcinomas (the TWINPEAK Study)
正在招募
Phase 2
药物
clinicaltrials.gov
NCT06461910
Efficacy and Safety of Anti-PD-1, Thymalfasin, and SOX in Neoadjuvant Treatment of cStage III Gastric/Gastroesophageal Junction Adenocarcinoma
正在招募
Phase 3
药物
clinicaltrials.gov
NCT05264896
Perioperative FLOT vs Adjuvant XELOX for CA Stomach
即将招募
Phase 2
药物
clinicaltrials.gov
NCT06706895
A Single-arm, Single-center Phase II Clinical Study on the Clinical Efficacy and Safety of Paclitaxel Polymeric Micelles for Injection Combined With Fruquintinib Capsules in the Second-line Treatment of Patients With Advanced Gastric Cancer
正在招募
阶段未标明
手术/操作
clinicaltrials.gov
NCT05561907
Enteral Anastomosis for the Treatment of Gastric Outlet Obstruction: A Randomized Controlled Study Comparing Endoscopic Versus Surgical Gastrojejunostomy
即将招募
Phase 3
药物手术/操作
clinicaltrials.gov
NCT07508956
Feasibility of Circulating Tumor DNA Based Minimal Residual Disease-Guided Adjuvant Therapy in Locally Advanced Gastric Cancer With Neoadjuvant Treatment
正在招募
Phase 1
药物
clinicaltrials.gov
NCT06663319
A Study of JNJ-89402638 for Metastatic Colorectal and Gastric Cancers
正在招募
阶段未标明
手术/操作
clinicaltrials.gov
NCT06731998
Optimal Perioperative Pain Control in Minimally Invasive Abdominal Cancer Surgery
正在招募
Phase 1, Phase 2
药物
clinicaltrials.gov
NCT05086692
A Beta-only IL-2 ImmunoTherapY Study
正在招募
Phase 2
药物放疗
clinicaltrials.gov
NCT05687357
Tislelizumab in Combination With Pre-operative CRT Versus SOC for Locally Advanced G/GEJ Adenocarcinoma
正在招募
Phase 2
药物
clinicaltrials.gov
NCT06711471
Trifluridine/tipiracil (TAS-102), Bevacizumab, and Camrelizumab As Third-line or Later-line Therapy of Gastric Cancer
正在招募
Phase 2
药物
clinicaltrials.gov
NCT07320586
Carilizumab and Albumin Paclitaxel for Second-line Treatment of Advanced Gastric Cancer
正在招募
Phase 1
药物
clinicaltrials.gov
NCT06882746
A Study to Test Different Doses of BI 765049 in People With Advanced Cancer of the Colon, Rectum, Stomach, or Pancreas
正在招募
Phase 2
药物
clinicaltrials.gov
NCT07556640
LM-302 and S-1 Plus Intraperitoneal Paclitaxel With or Without Cadonilimab for Claudin 18.2-positive Gastric or Gastroesophageal Junction Adenocarcinoma With Peritoneal Metastasis: a Prospective, Exploratory Study
正在招募
阶段未标明
药物
clinicaltrials.gov
NCT07098026
Shenqi Fuwei Mixture Combined With Chemotherapy Neoadjuvant Therapy for Locally Advanced Gastric Cancer
正在招募
Phase 1, Phase 2
药物
clinicaltrials.gov
NCT06766305
QL1706 Combined With SOX Used in Theperioperative Treatment
正在招募
阶段未标明
手术/操作
clinicaltrials.gov
NCT06597227
Proximal Gastrectomy vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy
正在招募
Phase 2
药物
clinicaltrials.gov
NCT06506292
A Phase II Trial of Perioperative Adebrelimab Combined With XELOX in Resectable Locally Advanced Gastric/Gastroesophageal Junction Cancer (GC/GEJC)
正在招募
Phase 3
药物
clinicaltrials.gov
NCT05078047
Study Comparing the Standard Administration of IO Versus the Same IO Administered Each 3 Months in Patients in Response After 6 Months of Standard IO
正在招募
Phase 3
药物手术/操作
clinicaltrials.gov
NCT05593458
Transarterial Neoadjuvant Chemotherapy vs.Traditional Intravenous Chemotherapy For Locally Advanced Gastric Cancer With SOX+PD-1
正在招募
阶段未标明
手术/操作
clinicaltrials.gov
NCT06839716
Comparison of Ropivacaine-Poloxamer 407 Hydrogel and TAP Block for Postoperative Pain Management in Laparoscopic/Robotic Gastrectomy
正在招募
Phase 1
药物
clinicaltrials.gov
NCT06586957
A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors
正在招募
Phase 2
药物
clinicaltrials.gov
NCT06155383
Perioperative Disitamab Vedotin Plus Toripalimab and XELOX in Gastric or Gastroesophageal Junction Adenocarcinoma.
正在招募
阶段未标明
手术/操作
clinicaltrials.gov
NCT07161479
Argon Plasma Coagulation Versus Endoscopic Mucosal Resection for Gastric Adenoma (CLER-GA)
即将招募
Phase 2
药物
clinicaltrials.gov
NCT07085273
Irinotecan Liposome II + 5-FU/LV + Oxaliplatin + Karelizumab in Neoadjuvant Treatment of Gastric Cancer
正在招募
Phase 3
药物
clinicaltrials.gov
NCT04342910
Study to Evaluate the Efficacy and Safety of Camrelizumab and Apatinib in Patients With GC/GEJC
正在招募
Phase 1
药物
clinicaltrials.gov
NCT07284186
First-in-Human Study of PLX-61639 in Locally Advanced or Metastatic Solid Tumors
正在招募
Phase 2
药物
clinicaltrials.gov
NCT05671822
Ph1b/2 Study of the Safety and Efficacy of SHR-A1811 Combinations in Advanced HER2 Expression Gastric Cancer
正在招募
Phase 3
药物
clinicaltrials.gov
NCT06755554
Investigation of Impact of Indocyanine Green on Volume of Lymphadenectomy in Resectable Gastric Cancer
正在招募
Phase 3
药物
clinicaltrials.gov
NCT04447352
HIPEC + FLOT vs. FLOT Alone in Patients With Gastric Cancer and GEJ (PREVENT)
正在招募
Phase 3
药物
clinicaltrials.gov
NCT07103668
A Phase III Randomized Study in CLDN18.2-positive Unresectable Locally Advanced Gastric Cancer Patients
即将招募
Phase 2
药物
clinicaltrials.gov
NCT05524974
Clinical Study of Camrelizumab, Apatinib Mesylate and Nab-paclitaxel Combined With Oxplatin and S-1 in the Neoadjuvant Treatment of Locally Advanced Gastric Cancer With Different Genotypes
正在招募
Phase 2, Phase 3
药物其他
clinicaltrials.gov
NCT06826079
Safety and Efficacy Study of Sorbitol With Neoadjuvant Chemotherapy Combined With Tirellizumab (PD-1 Inhibitor) in Patients With Locally Advanced Gastric Cancer
正在招募
阶段未标明
放疗
clinicaltrials.gov
NCT04097067
ISRT 20 Gy for Indolent Localized Gastrointestinal (GI)-Lymphoma
即将招募
EARLY / Phase 1
生物制剂
clinicaltrials.gov
NCT06432075
Neoantigen Reactive T Cells c for Chinese Patients With Advanced Gastric Cancer
正在招募
Phase 3
手术/操作
clinicaltrials.gov
NCT06608381
Comparison Partial Versus Total Omentectomy in Minimal Invasive Distal Gastrectomy for cT3/4a Gastric Cancer (KLASS-10)
正在招募
Phase 1
生物制剂药物
clinicaltrials.gov
NCT07594964
To Evaluate the Safety, Tolerability, and Preliminary Efficacy of XH001 Injection as Adjuvant Therapy in Patients With High-risk Recurrent Solid Tumors
正在招募
Phase 1
药物
clinicaltrials.gov
NCT07578571
A Phase 1 Study of IM-1617 in Participants With Advanced Cancer
即将招募
Phase 2
药物
clinicaltrials.gov
NCT06459921
Efficacy and Safety of Neoadjuvant Sintilimab Plus FLOT Versus Sintilimab Plus SOX Phase II Clinical Trial for Patients With Locally Advanced Gastric Cancer
正在招募
Phase 3
药物
clinicaltrials.gov
NCT07431281
Sonesitatug Vedotin in Combination With Capecitabine With or Without Rilvegostomig in Participants With Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma Expressing Claudin18.2
正在招募
Phase 1
生物制剂
clinicaltrials.gov
NCT05396300
A Clinical Study of CEA-targeted CAR-T in the Treatment of CEA-positive Advanced Malignant Solid Tumors
正在招募
阶段未标明
器械手术/操作
clinicaltrials.gov
NCT07586384
Single-port Versus Conventional Laparoscopic Surgery for Radical Proximal Gastric Cancer: A Randomized Controlled Trial
即将招募
Phase 2
药物手术/操作放疗
clinicaltrials.gov
NCT07243938
Phase II Basket Trial: Zanidatamab Plus Tislelizumab in HER2-Positive GI Tumors (UNION-HER2-BASKET)
正在招募
Phase 1, Phase 2
药物
clinicaltrials.gov
NCT05187338
Triplex Checkpoint Inhibitors Therapy for Advanced Solid Tumors
即将招募
Phase 2
药物
clinicaltrials.gov
NCT07669740
A Study on the Efficacy and Safety of Sintilimab Combined With Ramucirumab and Paclitaxel in the Treatment of Gastric Cancer Patients With Short-term Recurrence After Adjuvant Therapy
正在招募
阶段未标明
行为干预手术/操作
clinicaltrials.gov
NCT07441850
Digital Rehabilitation for Gastric Cancer Surgery After Neoadjuvant Therapy
即将招募
Phase 2
药物
clinicaltrials.gov
NCT07127822
Assessing Iparomlimab and Tuvonralimab in Recurrent or Metastatic MSI-H/dMMR Gastric Cancer
正在招募
Phase 2
药物
clinicaltrials.gov
NCT07483554
IBI343 in Combination Therapy for Advanced Malignant Solid Tumors
即将招募
Phase 2
药物
clinicaltrials.gov
NCT07374250
Perioperative Ivonescimab Plus S-1 and Oxaliplatin (SOX) for Locally Advanced Gastric or GEJ Adenocarcinoma
正在招募
Phase 3
药物
clinicaltrials.gov
NCT01935778
Compare Adjuvant Chemotherapy of Docetaxel/Capecitabine/Oxliplatin Versus Capecitabine/Oxaliplatin in Advanced Gastric Cancer at Stage IIIb and IV(KCSG ST15-08): TRIUMPH
正在招募
Phase 1, Phase 2
药物
clinicaltrials.gov
NCT06572319
Disitamab Vedotin Plus Trastuzumab in Patients With HER2 Positive GC/GEJ Patiens
正在招募
Phase 2
药物
clinicaltrials.gov
NCT07353684
Adebrelimab Plus Apatinib Combined With SOX Regimen as Conversion Therapy for Gastric Cancer
正在招募
Phase 2
药物
clinicaltrials.gov
NCT05771584
Therapeutic Cancer Vaccine (AST-301, pNGVL3-hICD) in Gastric Cancer
即将招募
Phase 3
药物
clinicaltrials.gov
NCT07673887
A Study of ASP2138 Together With Chemotherapy and Pembrolizumab in Adults With Gastric Cancer
正在招募
Phase 3
药物
clinicaltrials.gov
NCT07270991
Trifluridine/Tipiracil + Fruquintinib Versus Trifluridine/Tipiracil Alone for Metastatic Oeso-gastric Adenocarcinoma
即将招募
Phase 2
药物
clinicaltrials.gov
NCT07486310
Evaluation of Pressurized Intraperitoneal Aerosol Chemotherapy With VRT106 Versus PIPAC in Patients With Advanced Gastric Cancer and PeritonealMetastasis: A Prospective, Multicenter, Open-Label, Randomized Controlled Trial
正在招募
Phase 2
药物
clinicaltrials.gov
NCT06510010
Perioperative Oxaliplatin With S-1 Combined H. Pylori Eradication in the Management of Locally Advanced Gastric Cancer
即将招募
Phase 2
药物
clinicaltrials.gov
NCT07595523
Iparomlimab Tolvorlimab as Neoadjuvant Immunotherapy for Locally Advanced Gastric Adenocarcinoma With Microsatellite Instability/Mismatch Repair Deficiency
正在招募
Phase 2
药物手术/操作
clinicaltrials.gov
NCT06895447
Robotic Gastrectomy for Locally Advanced Gastric Cancer After Neoadjuvant Therapy
正在招募
Phase 1
药物
clinicaltrials.gov
NCT07182149
A Phase 1 Study of NRM-823 in Participants With Locally Advanced or Metastatic Refractory Solid Tumors
即将招募
Phase 2
药物
clinicaltrials.gov
NCT07685704
Zanidatamab Combined With Chemotherapy as Neoadjuvant/Conversion Therapy for HER2-Positive (IHC 3+ or IHC 2+) Advanced Gastric or Gastroesophageal Junction Adenocarcinoma: a Phase II Open-Label Study
正在招募
Phase 2
药物
clinicaltrials.gov
NCT05975749
Adjuvant Serplulimab and Trastuzuma and Chemotherapy in Her-2+ Gastric Cancer
正在招募
Phase 2
药物
clinicaltrials.gov
NCT07311408
SHR-1701 + Rivoceranib (± SHR-2554) in Advanced GC After First-Line Immunotherapy Failure
正在招募
Phase 2
药物
clinicaltrials.gov
NCT04114136
Anti-PD-1 mAb Plus Metabolic Modulator in Solid Tumor Malignancies
正在招募
Phase 2
药物放疗
clinicaltrials.gov
NCT07165847
Neoadjuvant Radiotherapy Plus Tegafur, Oxaliplatin and Iparomlimab and Tuvonralimab in Resectable Gastric and GE-junction Cancer : A Randomized, Two-arm, Prospective Trial (TRIUNITE-05)
正在招募
Phase 1
药物
clinicaltrials.gov
NCT07517198
Dose Determining Study of EXS74539 (REC-4539) in Participants With Select Solid Tumors
即将招募
Phase 3
药物
clinicaltrials.gov
NCT06093425
Combination of Osemitamab (TST001), Pembrolizumab and Chemotherapy as First-line Therapy in Advanced or Metastatic GC/GEJ Adenocarcinoma
正在招募
Phase 2
药物
clinicaltrials.gov
NCT06774222
A Study of Fruquintinib Plus Chemotherapy for Postoperative Treatment of HER2-Negative Gastric Cancer With Poor TRG
正在招募
Phase 2
药物
clinicaltrials.gov
NCT07432295
Givastomig Combined With Nivolumab and Chemotherapy in Adults With CLDN18.2 Positive Metastatic Gastric Cancer (GIVA-2)
正在招募
Phase 2
药物
clinicaltrials.gov
NCT06219941
AZD0901 in Participants With Advanced Solid Tumours Expressing Claudin18.2
正在招募
Phase 1
药物
clinicaltrials.gov
NCT06617169
Dose-Escalation of MNPR-101-PCTA-177Lu in Solid Tumors
正在招募
Phase 2
药物
clinicaltrials.gov
NCT06792162
PD-1 Antibody Carilizumab Combined with Apatinib for Unresectable Stage III and IV DMMR Gastric Cancer
正在招募
Phase 2
药物
clinicaltrials.gov
NCT07631000
A Study of Cadonilimab Combined With Chemotherapy in People With Gastric or Gastroesophageal Junction Cancer
即将招募
Phase 2
药物
clinicaltrials.gov
NCT06666166
SHR-A1811 Combined with Apatinib in the Treatment of Advanced Gastric or Gastroesophageal Junction Adenocarcinoma and Colorectal Cancer
正在招募
阶段未标明
手术/操作
clinicaltrials.gov
NCT02139605
"Phase III Randomized Trial Comparing D2 vs D3 Lymphadenectomy With Gastric Cancer Following Neoadjuvant Chemotherapy
正在招募
Phase 1, Phase 2
药物
clinicaltrials.gov
NCT06710756
Lead-212 PSV359 Therapy for Patients With Solid Tumors
即将招募
Phase 2
药物
clinicaltrials.gov
NCT06764251
Tislelizumab Combined with SOX Regimen in the Treatment of Locally Advanced Gastric Cancer/gastroesophageal Junction Adenocarcinoma
正在招募
Phase 3
药物
clinicaltrials.gov
NCT07385703
Clinical Study on the Efficacy and Safety of LM-302 Injection Combined With Tislelizumab and Tislelizumab Combined Chemotherapy for the Treatment of Gastric or Gastroesophageal Junction Adenocarcinoma.
正在招募
阶段未标明
手术/操作
clinicaltrials.gov
NCT07142122
Safety Comparison of Total Laparoscopic Proximal Gastrectomy With or Without Preservation of the Celiac Branch of the Vagus Nerve for Early Upper Gastric Cancer: A Randomized Controlled Clinical Trial
正在招募
Phase 2
生物制剂药物
clinicaltrials.gov
NCT06253611
First-line EXL01 With Nivolumab and FOLFOX for PD-L1 CPS ≥5 Metastatic Gastric Cancer
正在招募
Phase 1
生物制剂
clinicaltrials.gov
NCT06126406
Clinical Study of CEA Targeting Chimeric Antigen Receptor T Lymphocytes（CAR-T） for CEA Positive Advanced Malignant Solid Tumors
即将招募
Phase 1, Phase 2
药物
clinicaltrials.gov
NCT06871527
Fruquintinib Combined With PD-1 Inhibitor and FOLFOX as First-Line Treatment For Advanced Gastric Cancer
正在招募
阶段未标明
药物放疗
clinicaltrials.gov
NCT06349044
A Randomized, Multicenter Phase II Basket Study of Hypofractionated Radiotherapy/Stereotactic Body Radiotherapy Followed by Immunotherapy-Based Systemic Therapy +/- L. Rhamnosus M9 for the First-Line Treatment of Advanced Digestive System Malignancies.
正在招募
Phase 2
生物制剂药物手术/操作
clinicaltrials.gov
NCT06121700
Radiotherapy + Chemoimmunotherapy Followed by Surgery in Patients With Limited Metastatic Gastric or GEJ Cancer
正在招募
Phase 1
药物
clinicaltrials.gov
NCT07059299
A Phase Ib Trial Evaluating the Safety and Activity of Neoadjuvant Combination of Tislelizumab Plus FLOT for Resectable Esophagogastric Adenocarcinoma
正在招募
阶段未标明
手术/操作
clinicaltrials.gov
NCT06984952
Effectiveness of ERAS on Postoperative Recovery After Minimally Invasive Gastrectomy
正在招募
Phase 2
药物
clinicaltrials.gov
NCT07110571
A Trial of Adebrelimab Plus (SHR-A1811/SHR-A1904 With Chemotherapy) or SHR-8068 as Treatment for Gastric/GEJ Cancer
正在招募
Phase 2
药物放疗
clinicaltrials.gov
NCT07026149
Perioperative Treatment of Combined Radiotherapy With SOX, Apatinib and Camrelizumab for Oesophagogastric Cancer
正在招募
Phase 3
手术/操作
clinicaltrials.gov
NCT06161207
3D-4K-ICG Laparoscopic Gastrectomy for Gastric Cancer
即将招募
Phase 2
药物
clinicaltrials.gov
NCT06730581
Utidelone Capsule Monotherapy for Patients with Advanced Solid Tumors
正在招募
Phase 2
联合产品药物手术/操作
clinicaltrials.gov
NCT06313801
Comparing the Safety and Efficacy of First-line Polychemotherapy and Polychemotherapy in Combination With PIPAC Sessions
正在招募
Phase 1, Phase 2
生物制剂
clinicaltrials.gov
NCT06055439
A Phase 1/2 Study to Evaluate CHM-2101, an Autologous Cadherin 17 Chimeric Antigen Receptor (CAR) T Cell Therapy
正在招募
Phase 2
药物
clinicaltrials.gov
NCT06250036
Zimberelimab Anti-PD1 +/- Domvanalimab in Resectable Mmrd Gastric Cancer
即将招募
EARLY / Phase 1
药物
clinicaltrials.gov
NCT06525714
Effect of HIPEC After Radical Surgery on Long-term Survival for Locally Advanced Gastric Cancer
正在招募
Phase 2
药物
clinicaltrials.gov
NCT07294664
PD1/TGFβ In Combination With SHR2554 or Apatinib And Chemotherapy For First - Line Treatment Of Gastric Cancer
正在招募
Phase 1, Phase 2
生物制剂药物
clinicaltrials.gov
NCT06532799
TIL Therapy Combined With Pembrolizumab for Advanced or Metastatic Refractory Stomach and Esophageal Cancer
正在招募
Phase 1
药物
clinicaltrials.gov
NCT06610799
Study of IBI363 in Patients with Advanced First-line Gastric Cancer
即将招募
Phase 2
药物
clinicaltrials.gov
NCT05648487
HIPEC Combined With Sintilimab for Gastric Cancer With Peritoneal Metastasis
正在招募
阶段未标明
手术/操作
clinicaltrials.gov
NCT04890171
Comparison of Endoscopic Resection and Surgery for Early Gastric Cancer With Undifferentiated Histological Type
正在招募
Phase 1
联合产品药物
clinicaltrials.gov
NCT05768932
BAL0891 in Patients With Advanced Solid Tumors or Relapsed or Refractory Acute Myeloid Leukemia
正在招募
Phase 1, Phase 2
药物
clinicaltrials.gov
NCT05927857
Ramucirumab (Cyramza), Nal-IRI (ONIVYDE) and Trifluridine/Tipiracil (Lonsurf) in Second Line Metastatic Gastric Cancer .
正在招募
Phase 1, Phase 2
药物
clinicaltrials.gov
NCT06921928
Study for AZD4360 in Participants With Advanced Solid Tumours
即将招募
Phase 2
药物
clinicaltrials.gov
NCT07315035
QL1706-SOX vs SOX Alone as Neoadjuvant Therapy for Resectable Diffuse-Type Gastric Cancer
正在招募
Phase 1
药物
clinicaltrials.gov
NCT06769425
HS-10502 Combination Treatment in Patients With Advanced Solid Tumors
正在招募
Phase 2
药物
clinicaltrials.gov
NCT07070466
Ivonescimab in Comb. With FOLFOX in Advanced HER2 Neg. GEA
即将招募
阶段未标明
手术/操作
clinicaltrials.gov
NCT05356156
The Safe Study of Routine Closure of Mesenteric Defects Versus Non-closure After Radical Gastrectomy
正在招募
Phase 1, Phase 2
药物
clinicaltrials.gov
NCT06732856
A Phase Ib/II Trial of Neoadjuvant Zolbetuximab Plus Docetaxel, Oxaliplatin and S-1 Chemotherapy in Patients With Locally Advanced Gastric Cancer
正在招募
Phase 2
药物
clinicaltrials.gov
NCT05620628
Ph2 Study of Savolitinib and Durvalumab (MEDI4736) Combination in Advanced MET Amplified Gastric Cancer(VIKTORY-2)
正在招募
Phase 1, Phase 2
药物
clinicaltrials.gov
NCT07262619
EIK1005-002: A Clinical Research Study Evaluating EIK1005, a Werner Helicase Inhibitor, as Monotherapy and in Combination With Pembrolizumab in Participants With Advanced Solid Tumors Including Microsatellite Instability High (MSI-H) Tumors
正在招募
阶段未标明
手术/操作
clinicaltrials.gov
NCT06778954
Ropivacaine-Poloxamer 407 Gel for Pain Control After Open Gastrectomy
正在招募
Phase 2
药物
clinicaltrials.gov
NCT07194005
Conversion Therapy With RC48, Sintilimab, and SOX for HER2 1+/2+ Unresectable Gastric Cancer
正在招募
Phase 1, Phase 2
药物
clinicaltrials.gov
NCT06399757
A Study to Investigate APL-5125 in Adults With Advanced Solid Tumors
正在招募
Phase 1
生物制剂
clinicaltrials.gov
NCT06821048
Study of CEA Targeting CAR-T (PTC13) in the Treatment of CEA-Positive Advanced Malignant Solid Tumors
正在招募
阶段未标明
生物制剂
clinicaltrials.gov
NCT05620732
Treatment of Advanced Malignant Solid Tumors With Claudin18.2CAR-T
即将招募
Phase 3
药物
clinicaltrials.gov
NCT07314203
Clinical Efficacy of Adebrelimab With or Without Apatinib Mesilate and SOX Neoadjuvant Therapy in Locally Advanced Gastric Cancer
正在招募
Phase 2
药物
clinicaltrials.gov
NCT06371586
Neo-Sequence 2：NCT Plus Anti-angiogenesis Therapy and Immunotherapy for LADGC
即将招募
Phase 1
药物
clinicaltrials.gov
NCT07252661
Study of ACC-1898 in Adult Participants With Advanced Solid Tumors
正在招募
阶段未标明
手术/操作
clinicaltrials.gov
NCT06791538
Robotic Versus Laparoscopic Radical Surgery for Locally Advanced Gastric Cancer
正在招募
Phase 3
药物
clinicaltrials.gov
NCT06793917
Tislelizumab Plus FOLFOX Versus POF in the Treatment of Locally Advanced: a Multicenter, Open-label, Randomized Phase III Studyunresectable or Metastatic Gastric/Gastroesophageal Junction Adenocarcinoma
正在招募
Phase 1
生物制剂
clinicaltrials.gov
NCT04147078
Personalized DC Vaccine for Postoperative Cancer
正在招募
Phase 1
药物
clinicaltrials.gov
NCT06500052
A Study of BL-M17D1 in Patients With Locally Advanced or Metastatic HER2 Positive/Lower Expression Gastrointestinal Cancer and Other Solid Tumors
正在招募
Phase 2
生物制剂药物
clinicaltrials.gov
NCT07212933
The Safety and Clinical Efficacy of RAK Cell Therapy in Late-stage Gastric Cancer: A Randomized Controlled Trial
正在招募
Phase 2
药物
clinicaltrials.gov
NCT07554521
A Study to Evaluate Efficacy and Safety of Tislelizumab Plus Chemotherapy for Locally Advanced Unresectable or Metastatic Gastric or Gastroesophageal Adenocarcinoma and Esophageal Squamous Cell Carcinoma in Racial and Ethnic Minority Patients in the United States
正在招募
Phase 1
药物
clinicaltrials.gov
NCT07390838
A Study of SH009 Injection in Patients With Advanced Solid Tumors.
正在招募
Phase 2
手术/操作
clinicaltrials.gov
NCT07178808
PHASE II EVALUATION OF CYTOREDUCTION SURGERY AND HYPERTHERMIC INTRAPERITONEAL CHEMOTHERAPY (CRS/HIPEC) IN GASTRIC CANCER
正在招募
Phase 1
药物
clinicaltrials.gov
NCT05208762
A Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors
正在招募
Phase 2
药物
clinicaltrials.gov
NCT07492615
A Clinical Study of Sintilimab Combined With Chemothrapy Versus Chemotherapy as Adjuvant Therapy for Gastric/Gastroesophageal Junction Adenocarcinoma
正在招募
阶段未标明
手术/操作
clinicaltrials.gov
NCT06300879
A Prospective Study on Esophagogastrostomy by an Innovative Surgical Technique
即将招募
Phase 4
药物
clinicaltrials.gov
NCT07132528
Comparing the Efficacy and Safety of Chemotherapy Combined With or Without Immunotherapy as an Adjuvant Treatment After Radical Surgery for Patients With Resectable Adenocarcinoma of the Esophagogastric Junction of Gastric Cancer
正在招募
Phase 2
药物
clinicaltrials.gov
NCT06059495
Watch-and-Wait Approach With Dostarlimab in Localized dMMR/MSI-H Gastric Cancer: GERCOR Phase II Study
即将招募
阶段未标明
手术/操作
clinicaltrials.gov
NCT06741501
Preliminary Efficacy Analysis of "C" Single Flap Plasty Reconstruction After Laparoscopic Proximal Gastrectomy
即将招募
Phase 1, Phase 2
药物
clinicaltrials.gov
NCT06266871
SOX Combined With Tislelizumab and LDRT for Neoadjuvant Treatment of Locally Advanced Gastric Cancer
即将招募
Phase 2
药物放疗
clinicaltrials.gov
NCT07101666
Total Neoadjuvant Therapy With Short Course Radiation Therapy in Gastric Cancer
正在招募
Phase 3
药物
clinicaltrials.gov
NCT05918094
Comparing Modified XELOX Plus Sintilimab With Standard XELOX Plus Sintilimab in First-line Treatment for HER2-negative Gastric/Gastroesophageal Junction Adenocarcinoma
即将招募
Phase 2
药物
clinicaltrials.gov
NCT07655661
Mannatide Combined With CAPOX and Tislelizumab for Advanced Gastric Cancer.
正在招募
Phase 2
药物
clinicaltrials.gov
NCT06157996
Lenvatinib Plus Tislelizumab and CapeOX as First-Line Treatment for Advanced GC/GEJC With Positive PD-L1 and Low TMEscore
即将招募
阶段未标明
手术/操作
clinicaltrials.gov
NCT06421220
Evaluation of the Efficacy and Safety of Indocyanine Green Tracing in 3D Fluorescent Laparoscopic Lymph Node Dissection for Gastric Cancer
即将招募
Phase 2
药物
clinicaltrials.gov
NCT06492317
RC48 Plus AK104 as First-line Treatment for HER2-overexpressing Advanced Gastric Cancer
即将招募
Phase 3
联合产品
clinicaltrials.gov
NCT05270824
Study Evaluating Neoadjuvant Immunotherapy Increasing CD8+ Cell Infiltration in Advance Gastric Adenocarcinoma
正在招募
Phase 2
药物
clinicaltrials.gov
NCT06487429
Short Course Radiotherapy With Sequential Disitamab Vedotin Combined With S-1 and Sintilimab as Whole Course Neoadjuvant Therapy for HER2 Expressed Locally Progressive Gastric Cancer
正在招募
Phase 2
药物
clinicaltrials.gov
NCT05536102
The Effectiveness and Safety of XELOX and Tislelizumab + PLD for Resectable Gastric Cancer (LidingStudy)
即将招募
阶段未标明
手术/操作
clinicaltrials.gov
NCT03857737
Endoscopic Submucosal Dissection Versus Surgery in the Treatment of Early Gastric Cancer
即将招募
Phase 2
药物
clinicaltrials.gov
NCT06888037
Fruquintinib Combined With PD-1 Inhibitor as First-line Maintenance Therapy for Advanced Gastric Cancer
正在招募
Phase 3
药物
clinicaltrials.gov
NCT07366528
Adjuvant Oxaliplatin Plus S-1 Versus Docetaxel Plus S-1 for Stage III Gastric Cancer
正在招募
阶段未标明
药物
clinicaltrials.gov
NCT07552402
Oral Paclitaxel Plus Fruquintinib Verus Investigator's Choice in Second-Line Advanced Gastric Cancer
正在招募
阶段未标明
手术/操作
clinicaltrials.gov
NCT06042998
A Multicenter, RCT Study of the Clinical Efficacy of Robotic and Laparoscopic Gastrectomy in Neoadjuvant Gastric Cancer
正在招募
Phase 2, Phase 3
药物
clinicaltrials.gov
NCT06504732
To Evaluate IAH0968 in Combination With CAPEOX in HER2-positive Gastric Cancer
正在招募
Phase 4
药物
clinicaltrials.gov
NCT07139366
Saccharomyces Boulardii Combined With Bismuth Quadruple Therapy for Helicobacter Pylori Rescue Treatment
正在招募
Phase 2
药物
clinicaltrials.gov
NCT05702229
Novel Combinations in Participants With Locally Advanced Unresectable or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma
正在招募
EARLY / Phase 1
生物制剂药物
clinicaltrials.gov
NCT05041153
Pembrolizumab and Lenvatinib for the Treatment of Advanced, Unresectable, or Metastatic Gastroesophageal Adenocarcinoma
即将招募
阶段未标明
手术/操作
clinicaltrials.gov
NCT04795063
Total Robotic Versus Robotic Assisted Distal Gastrectomy for Gastric Cancer
正在招募
阶段未标明
生物制剂Dietary_Supplement药物
clinicaltrials.gov
NCT06128252
Clinical Study of Taurine Combined With Neoadjuvant Chemo-Immunotherapy for Treatment of Locally Advanced Gastric Cancer
正在招募
Phase 1, Phase 2
药物
clinicaltrials.gov
NCT07354711
A First-in-human Study of 3H-10000 in Patients With Unresectable or Metastatic Solid Tumors
即将招募
Phase 2
药物
clinicaltrials.gov
NCT07507916
Dynamic ctDNA-Guided Adjuvant Therapy in cStage III and IVA Gastric or Gastroesophageal Junction Adenocarcinoma
正在招募
Phase 3
药物其他
clinicaltrials.gov
NCT06313567
Metronomic Capecitabine in Stage III Gastric Cancer
正在招募
Phase 1, Phase 2
药物
clinicaltrials.gov
NCT06005493
Study of AZD5863 in Adult Participants With Advanced or Metastatic Solid Tumors
即将招募
Phase 2
药物
clinicaltrials.gov
NCT06748508
Comparing the Efficacy of Sintilimab Plus Nab-POF Regimen, Sintilimab Plus XELOX Chemotherapy, and Lenvatinib, Sintilimab Plus XELOX Chemotherapy in the Treatment of HER2-negative, Metastatic Gastric Cancer
正在招募
阶段未标明
手术/操作
clinicaltrials.gov
NCT05450835
OGT-assisted Overlap Esophagojejunostomy Versus Traditional Overlap Method
正在招募
Phase 1
药物
clinicaltrials.gov
NCT05277766
Intraperitoneal Aerosolized Nanoliposomal Irinotecan (Nal-IRI) in Peritoneal Carcinomatosis From Gastrointestinal Cancer
即将招募
Phase 2
药物
clinicaltrials.gov
NCT06439550
Adjuvant Treatment With Serplulimab，Trastuzumab and SOX in the HER-2 Positive GC/GEJC
即将招募
Phase 1, Phase 2
生物制剂
clinicaltrials.gov
NCT07333573
A Hypoxia-Inducible CAR-T Cell Targeting AXL and CD73 for Advanced Gastric Cancer
正在招募
Phase 1
药物
clinicaltrials.gov
NCT06266299
A Study of KK2269 in Adult Participants With Solid Tumors
正在招募
Phase 3
药物
clinicaltrials.gov
NCT06532006
A Phase Ⅲ Clinical Study of HLX22 in Combination With Trastuzumab and Chemotherapy for the Treatment of Gastroesophageal Junction and Gastric Cancer
正在招募
Phase 4
药物
clinicaltrials.gov
NCT05183126
Pharmacokinetic Study of Skeletal Muscle Area-based Paclitaxel Infusion in Patients With Cancer
正在招募
阶段未标明
放疗
clinicaltrials.gov
NCT05370144
A Study Involving Neoadjuvant Chemoradiotherapy with Hypofractionated Radiotherapy in Patients with Esophageal and Gastroesophageal Junction Adenocarcinoma
正在招募
Phase 1
药物
clinicaltrials.gov
NCT04361708
Safety of Combining Irinotecan With 5-FU, Leucovorin/Folinic Acid, Oxaliplatin, and Docetaxel Chemotherapies
正在招募
Phase 2
药物放疗
clinicaltrials.gov
NCT07018570
An Open Label Phase 2 Study of Total Neoadjuvant Therapy (TNT) Consisting of FLOT With Pembrolizumab and Short Radiation for Patients With Locally Advanced Gastroesophageal Junction Adenocarcinoma
即将招募
Phase 2
药物
clinicaltrials.gov
NCT06469060
Neoadjuvant Immunochemotherapy for Adenocarcinoma of the Esophagogastric Junction
正在招募
Phase 2
药物
clinicaltrials.gov
NCT04771520
Avapritinib for the Treatment of CKIT or PDGFRA Mutation-Positive Locally Advanced or Metastatic Malignant Solid Tumors
即将招募
Phase 3
药物
clinicaltrials.gov
NCT06411171
Safety and Efficacy of Pembrolizumab in Combination With FLOT About Gastroesophageal Junction Cancer:
即将招募
Phase 2
药物
clinicaltrials.gov
NCT07625930
RESTAGE (REpurposing STAtins to Improve Outcomes in GastroEsophageal Cancer) Trial
正在招募
阶段未标明
手术/操作
clinicaltrials.gov
NCT06162767
Cancer of Esophagogastric Junction: Optimized Sweet Versus Ivor-Lewis
正在招募
阶段未标明
手术/操作
clinicaltrials.gov
NCT06644352
Right Versus Left Thoracic Surgical Approaches for Siewert II Gastroesophageal Junction Adenocarcinoma
正在招募
Phase 2
药物手术/操作
clinicaltrials.gov
NCT05733000
CPI-613 (Devimistat) in Combination With Hydroxychloroquine and 5-fluorouracil or Gemcitabine in Treating Patients With Advanced Chemorefractory Solid Tumors
正在招募
Phase 3
药物放疗
clinicaltrials.gov
NCT04821778
Chemoradiotherapy in Esophageal or Esophagogastric Junction Cancer
即将招募
阶段未标明
手术/操作
clinicaltrials.gov
NCT07408999
Totally Versus Hybrid Minimally Invasive Esophagectomy for Esophageal Cancer
正在招募
Phase 2
药物
clinicaltrials.gov
NCT06161818
Total Neoadjuvant Therapy for Lymph Node-positive Adenocarcinoma of the OESophagus and Oesophagogastric Junction
正在招募
Phase 2
药物
clinicaltrials.gov
NCT05563766
A Phase II Trial to Evaluate the Effect of Itraconazole on Pathologic Complete Response Rates in Resectable Esophageal Cancer
正在招募
Phase 1, Phase 2
药物
clinicaltrials.gov
NCT06329973
Fruquintinib in Combination With Sintilimab and CAPEOX as First-line Treatment for G/GEJ Cancer
正在招募
Phase 2
药物放疗
clinicaltrials.gov
NCT04656041
Folfox+Irinotecan+Chemort In Esophageal Cancer
正在招募
Phase 1, Phase 2
生物制剂药物
clinicaltrials.gov
NCT06445972
Substudy 06D: Combination Therapies in Second Line (2L) Gastroesophageal Adenocarcinoma (MK-3475-06D/Keymaker-U06)
正在招募
Phase 2
药物
clinicaltrials.gov
NCT04018872
Evaluating the Effect of Itraconazole on Pathologic Complete Response Rates in Esophageal Cancer
正在招募
Phase 1
药物
clinicaltrials.gov
NCT07090499
A Study to Learn About the Study Medicine Called PF-08046876 in People With Advanced Solid Tumors
正在招募
Phase 1
药物其他放疗
clinicaltrials.gov
NCT04615013
NBTXR3, Chemotherapy, and Radiation Therapy for the Treatment of Esophageal Cancer
正在招募
Phase 1
药物
clinicaltrials.gov
NCT04511039
Trifluridine/Tipiracil and Talazoparib for the Treatment of Patients With Locally Advanced or Metastatic Colorectal or Gastroesophageal Cancer
第 1 页
没有符合当前筛选条件的试验。
Subtypes
建议拆分方向
gastric cancergastroesophageal junction cancer / GEJHER2-positiveCLDN18.2PD-L1MSI-H / dMMRadvanced gastric cancermetastatic gastric cancer
Keyword guide
这些关键词怎么理解
| 术语 | 中文意思 | 对找临床试验有什么用 |
|---|---|---|
| 胃癌 / Gastric cancer | 发生在胃部的恶性肿瘤。海外记录中也常写 stomach cancer。 | 可以同时尝试 gastric cancer 和 stomach cancer。 |
| 胃食管结合部癌 / GEJ cancer | 发生在胃和食管交界区域的癌症，部分试验会和胃癌一起招募。 | 搜索时可加入 gastroesophageal junction 或 GEJ。 |
| HER2-positive | 部分胃癌或 GEJ 癌存在 HER2 高表达或扩增。 | 可以找 HER2 靶向药、ADC、联合治疗相关试验。 |
| CLDN18.2 | Claudin 18.2 是胃癌中常见研究靶点之一。 | 可以找 CLDN18.2 antibody、CAR-T、ADC 等相关试验。 |
| PD-L1 | 和免疫治疗相关的生物标志物，常用 CPS 表达。 | 免疫治疗试验可能要求 PD-L1 CPS 或按其分层。 |
| MSI-H / dMMR | 提示微卫星高度不稳定或错配修复异常。 | 可以找免疫治疗相关试验。 |
Recruitment status
常见招募状态
| Recruiting | 正在招募，可能仍可申请参加。 |
| Not yet recruiting | 尚未开始招募，可关注后续开放时间。 |
| Active, not recruiting | 试验仍在进行，但通常不再招新患者。 |
| Completed | 试验已经完成。 |
| Terminated | 试验提前终止。 |
| Unknown | 公开页面上的状态不明确或未及时更新。 |
Before contact
联系前准备资料
- 病理诊断报告
- 影像报告：CT / MRI / PET-CT
- 既往治疗记录
- 用药历史
- 基因检测报告
- 最近血液检查结果
- 出院小结
- 主治医生英文病情摘要，如果有
- 护照和签证情况，如果考虑出国
Filters
搜索时重点关注
- Recruiting / Not yet recruiting
- Location
- Age
- Phase
- Inclusion Criteria
- Exclusion Criteria
- Prior treatments
- Biomarker / mutation requirements
- ECOG performance status
- 是否接受 international patients
- 是否需要长期停留在试验所在地
- 费用、保险、翻译、住宿和陪护安排
Ask your doctor
可以带去问医生的问题
- 我的病理类型是否符合这个试验？
- 我之前用过的药会不会影响入组？
- 我是否需要做基因检测？
- 这个试验是几期？主要目的是什么？
- 参加试验会不会影响当前治疗？
- 如果去国外参加，风险和成本大概有哪些？
- 研究团队是否接受海外患者？
请将检索到的临床试验信息带给主治医生或肿瘤科医生讨论。本站不判断患者是否适合任何临床试验。